0001213900-19-010344.txt : 20190607 0001213900-19-010344.hdr.sgml : 20190607 20190607171526 ACCESSION NUMBER: 0001213900-19-010344 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190607 DATE AS OF CHANGE: 20190607 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MyDx, Inc. CENTRAL INDEX KEY: 0001582341 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 990384160 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55596 FILM NUMBER: 19886842 BUSINESS ADDRESS: STREET 1: 6335 FERRIS SQUARE STREET 2: SUITE B CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 800-814-4550 MAIL ADDRESS: STREET 1: 6335 FERRIS SQUARE STREET 2: SUITE B CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BRISTA CORP. DATE OF NAME CHANGE: 20130724 10-Q 1 f10q0319_mydxinc.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission File Number 000-55596

MyDx, Inc.

(Exact Name of Registrant as Specified in its Charter)

Nevada		99-0384160
State or Other Jurisdiction of Incorporation or Organization		I.R.S. Employer Identification No.

6335 Ferris Square, Suite B San Diego, CA		92121
Address of Principal Executive Offices		Zip Code

(800) 814-4550

Registrant’s Telephone Number, Including Area Code

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		None		None

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

4,070,747,508 shares of common stock, par value $0.001 per share, issued and outstanding as of June 7, 2019.

MyDx, INC.

TABLE OF CONTENTS

		Page

PART I.	FINANCIAL INFORMATION

Item 1.	Financial Statements:	1

	Condensed Consolidated Balance Sheets as of March 31, 2019 (Unaudited) and December 31, 2018	1

	Condensed Consolidated Statements of Operations for the Three-month Periods Ended March 31, 2019 and 2018 (Unaudited)	2

	Condensed consolidated Statement of Stockholders’ Equity for the Three Months Ended March 31, 2019 and 2018 (Unaudited)	3

	Condensed Consolidated Statements of Cash Flows for the Three-month Periods Ended March 31, 2019 and 2018 (Unaudited)	4

	Notes to Condensed Consolidated Financial Statements (Unaudited)	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21

Item 3.	Quantitative and Qualitative Disclosure About Market Risk	22

Item 4.	Controls and Procedures	26

PART II.	OTHER INFORMATION

Item 1.	Legal Proceedings	27

Item 1A.	Risk Factors	28

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	28

Item 3.	Defaults Upon Senior Securities	28

Item 4.	Mine Safety Disclosures	28

Item 5.	Other Information	28

Item 6.	Exhibits	28

SIGNATURES		29

PART I. FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

MyDx, Inc.

Condensed Consolidated Balance Sheets

	March 31, 2019			December 31, 2018
	(unaudited)
ASSETS

Current assets:
Cash	$	175,504		$	102,698
Inventory		157,956			114,031
Total current assets		333,460			216,729

Tooling in process		173,854			173,854
Property and equipment, net		20,589			26,748
Other assets		18,983			18,983
Total assets	$	546,886		$	436,314

LIABILITIES AND STOCKHOLDERS’ DEFICIT

Current liabilities:
Accounts payable	$	1,168,852		$	1,101,853
Customer deposits		155,752			69,330
Accrued liabilities		734,179			692,071
Current portion of leases payable		2,756			2,756
Due to related party		1,075			1,075
Convertible notes payable, current, net of debt discount		595,499			436,177
Derivative liability		1,253,732			1,222,186
Preferred shares liability		2,850,401			2,850,401
Warrant liability		4,851,348			6,267,426
Total current liabilities		11,613,594			12,643,275

Total liabilities		11,613,594			12,643,275

Redeemable Series B Preferred stock, $0.001 par value; 10,000,000 shares authorized 107,000 and 107,000 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively		2,033,000			2,033,000

Commitments and contingencies

Stockholders’ deficit:
Series A Preferred stock, $0.001 par value; 51 shares authorized 51 and 51 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively		-			-
Common stock, $0.001 par value, 10,000,000,000 shares authorized; 4,070,747,508 and 3,905,200,946 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively		4,070,747			3,905,201
Additional paid-in capital		22,500,405			21,820,069
Accumulated deficit		(39,670,860	)		(39,965,231	)
Total stockholders’ deficit		(13,099,708	)		(14,239,961	)
Total liabilities and stockholders’ deficit	$	546,886		$	436,314

The accompanying notes are an integral part of these condensed consolidated financial statements.

MYDX INC.

Condensed Consolidated Statements of Operations

(unaudited)

	For the Three Months Ended March 31,
	2019			2018
Sales
Product revenue	$	1,251		$	66,844
Product service revenue		288			5,455
Licensing revenue		-			4,130
Total sales		1,539			76,429

Cost of goods sold
Product costs		16,883			26,338
Total cost of sales		16,883			26,338

Gross profit		(15,344	)		50,091

Operating Expenses
Research and development		13,935			233,090
Sales and marketing		54,290			52,253
General and administrative		426,922			245,647
Total operating expenses		495,147			530,990

Loss from operations		(510,491	)		(480,899	)

Other income (expense)
Interest expense, net		(146,353	)		(8,751	)
Change in fair value of derivative liability		135,244			1,519,057
Change in fair value of warrant liability		815,970			-
Derivative expense		-			(154,002	)
Gain on settlement of debt		-			4,500
Total Other income (expense)		804,861			1,360,804

Income before provision for income taxes		294,370			879,905

Provision for income taxes		-			-
Net Income	$	294,370		$	879,905

Dividends		10,700			-

Net Income attributable to common shareholders	$	283,670		$	879,905

Loss per share
Basic	$	0.00		$	0.00
Diluted	$	(0.00	)	$	(0.00	)

Weighted average common shares outstanding - basic		4,043,156,414			1,878,730,874
Weighted average common shares outstanding - diluted		7,797,250,837			5,320,872,536

The accompanying notes are an integral part of these condensed consolidated financial statements.

MyDx, INC.

Statements of Stockholders’ Deficit

For the Periods Ended March 31, 2019 and 2018

(unaudited)

	Convertible Preferred Stock Series A				Common Stock				Additional Paid-in		Accumulated			Shareholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balances as of December 31, 2018		51	$	-		3,905,200,946	$	3,905,201	$	21,820,069	$	(39,965,231	)	$	(14,239,961	)

Issuance of common stock upon cashless exercise of warrants		-		-		165,546,562		165,546		680,336		-			845,882

Net income for three months ended March 31, 2019		-		-		-		-		-		294,370			294,370

Balance as of March 31, 2019	$	51	$	-	$	4,070,747,508	$	4,070,747	$	22,500,405	$	(39,670,860	)	$	(13,099,708	)

	Convertible Preferred Stock Series A				Common Stock				Additional Paid-in		Accumulated			Shareholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balances as of December 31, 2017		51	$	-		1,859,397,541	$	1,859,397	$	19,818,536	$	(31,632,972	)	$	(9,555,039	)

Issuance of common stock for services rendered		-		-		30,000,000		30,000		120,000		-			150,000

Common stock issued to settle vendor liabilities		-		-		5,000,000		5,000		20,500		-			25,500

Stock based compensation		-		-		-		-		1,971		-			1,971

Net income for three months ended March 31, 2018		-		-		-		-		-		879,905			879,905

Balance as of March 31, 2018		51	$	-		1,894,397,541	$	1,894,397	$	19,961,007	$	(30,753,067	)	$	(8,897,604	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

MyDx, INC.

Condensed Consolidated Statements of Cash Flows

(unaudited)

	For the Three Months Ended March 31,
	2019			2018
Cash flows from operating activities:
Net income	$	294,370		$	879,905
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization		6,159			18,893
Common stock issued in exchange for services		-			150,000
Change in fair value of derivative liability		(135,244	)		(1,519,057	)
Change in fair value of warrant liability		(815,970	)		-
Derivative expense		-			154,002
Gain on settlement of vendor liabilities		-			(4,500	)
Stock based compensation		245,775			151,971
Interest expense related to amortization of debt issuance costs and debt discount		126,112			-
Changes in assets and liabilities:					-
Inventory		(43,925	)		10,071
Prepaid expenses and other assets		-			6,918
Tooling in process		-			(137,641	)
Accounts payable and accrued liabilities		109,107			358,431
Customer deposits		86,422			(431	)
Net cash used in operating activities		(127,194	)		(81,438	)

Cash flows from financing activities
Proceeds from note payable, net of issuance costs		200,000			-
Net cash provided by financing activities		200,000			-

Net change in cash		72,806			(81,438	)

Cash, beginning of period		102,698			119,028
Cash, end of period	$	175,504		$	37,590

Supplemental cash flow information:
Interest paid	$	-		$	13,755
Taxes paid	$	-		$	-

Supplemental disclosure of non-cash investing and financing activities:
Stock issued for settlement of vendor liabilities	$	-		$	25,500
Reclassification of warrant liability to additional paid-in capital upon exercise of warrant	$	845,883		$	-

The accompanying notes are an integral part of these condensed consolidated financial statements.

MyDx, INC.

Notes to Condensed Consolidated Financial Statements

1.	Organization

MyDx, Inc. (the “Company”, “we”, “us” or “our”) (formally known as Brista Corp.) was incorporated under the laws of the State of Nevada on December 20, 2012. The Company’s wholly owned subsidiary, CDx, Inc., was incorporated under the laws of the State of Delaware on September 16, 2013.

2.	Nature of Business

MyDx is a science and technology company that develops and deploys products and services in the following focus areas:

Consumer Products – smart devices and consumables

Data Analytics – pre-clinical chemical analysis and patient feedback ecosystem

Biopharmaceuticals – identifying ‘green Active Pharmaceutical Ingredients^TM, (gAPI^TM) and corresponding formulations

Software as a Service (SaaS) – Software services for prescribers, patient groups, cultivators, and regulators

We are committed to addressing areas of critical national need to promote public safety, transparency and regulation in the various markets we serve.

The Company’s first product, MyDx^®, also known as “My Diagnostic”, is a patented multiuse hand-held chemical analyzer made for consumers and professional users which feeds our data analytics platform and SaaS business. MyDx is intended to allow consumers to Trust & Verify^® what they put into their mind and body by using our science and technology to test for pesticides in food, chemicals in water, toxins in the air, and the safety and potency of cannabis samples, which is our initial focus.

3.	Going Concern

The Company’s condensed consolidated financial statements have been prepared assuming it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

As reflected in the condensed consolidated Financial Statements, the Company had an accumulated deficit at March 31, 2019 and a net cash used in operating activities for the three months ended March 31, 2019. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

The Company is attempting to further implement its business plan and generate sufficient revenues; however, its cash position may not be sufficient to support its daily operations. The Company has a limited operating history and its prospects are subject to risks, expenses and uncertainties frequently encountered by early-stage companies. These risks include, but are not limited to, the uncertainty of availability of financing and the uncertainty of achieving future profitability. Management anticipates that the Company will be dependent, for the near future, on investment capital to fund operating expenses. The Company intends to position itself so that it may be able to raise funds through the capital markets. There can be no assurance that such financing will be available at terms acceptable to the Company, if at all. Failure to generate sufficient cash flows from operations, raise capital or reduce certain discretionary spending could have a material adverse effect on the Company’s ability to achieve its intended business objectives. We reported negative cash flow from operations for the three months ended March 31, 2019. It is anticipated that we will continue to report negative operating cash flow in future periods, likely until one or more of our products generate sufficient revenue to cover our operating expenses. If any of the warrants are exercised, all net proceeds of the warrant exercise will be used for working capital to fund negative operating cash flow.

Our cash balance of $175,504 at March 31, 2019 will not be sufficient to fund our operations for the next 12 months. Additionally, if we are unable to generate sufficient revenues to pay our expenses, we will need to raise additional funds to continue our operations. We have historically financed our operations through private equity and debt financings. We do not have any commitments for financing at this time, and financing may not be available to us on favorable terms, if at all. If we are unable to obtain debt or equity financing in amounts sufficient to fund our operations, if necessary, we will be forced to suspend or curtail our operations. In that event, current stockholders would likely experience a loss of most or all of their investment. Additional funding that we do obtain may be dilutive to the interests of existing stockholders.

The condensed consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

4.	Summary of Significant Accounting Policies

Basis of Presentation - Unaudited Interim Financial Information

The accompanying unaudited interim condensed consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) with respect to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s annual report on Form 10-K for the year ended December 31, 2018.

Use of Estimates

The preparation of the consolidated finance statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Such management estimates include allowance for doubtful accounts, estimates of product returns, warranty expense, inventory valuation, valuation allowances of deferred taxes, stock-based compensation expenses and fair value of warrants and derivatives. The Company bases its estimates on historical experience and on assumptions that it believes are reasonable. The Company assesses these estimates on a regular basis; however, actual results could materially differ from those estimates.

Concentration of Risk Related to Third-party Suppliers

We depend on a limited number of third-party suppliers for the materials and components required to manufacture our products. A delay or interruption by our suppliers may harm our business, results of operations, and financial condition, and could also adversely affect our future profit margins. In addition, the lead time needed to establish a relationship with a new supplier can be lengthy, and we may experience delays in meeting demand in the event we must change or add new suppliers. Our dependence on our suppliers exposes us to numerous risks, including but not limited to the following: our suppliers may cease or reduce production or deliveries, raise prices, or renegotiate terms; we may be unable to locate a suitable replacement supplier on acceptable terms or on a timely basis, or at all; and delays caused by supply issues may harm our reputation, frustrate our customers, and cause them to turn to our competitors for future needs.

Fair Value of Financial Instruments

The Company recognizes and discloses the fair value of its assets and liabilities using a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). Each level of input has different levels of subjectivity and difficulty involved in determining fair value.

	Level 1	Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurable date.

	Level 2	Inputs, other than quoted prices included in Level 1, that are observable for the asset or liability through corroboration with market data at the measurement date.

	Level 3	Unobservable inputs that reflect management’s best estimate of what participants would use in pricing the asset or liability at the measurement date.

The carrying amounts of the Company’s financial assets and liabilities, including cash, accounts receivable, accounts payable, and accrued liabilities approximate fair value because of the short maturity of these instruments. The carrying value of the Company’s loan payable and convertible notes payable approximates fair value based upon borrowing rates currently available to the Company for loans with similar terms.

Business Segments

ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company’s condensed consolidated financial statements as substantially all of the Company’s operations are conducted in one industry segment.

Cash

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. As of March 31, 2019 and December 31, 2018, the Company held no cash equivalents.

The Company’s policy is to place its cash with high credit quality financial instruments and institutions and limit the amounts invested with any one financial institution or in any type of instrument. Deposits held with banks may exceed the amount of insurance provided on such deposits. The Company has not experienced any losses on its deposits of cash.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are recorded at the invoiced amount and are not interest bearing. The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. The Company makes ongoing assumptions relating to the collectability of its accounts receivable in its calculation of the allowance for doubtful accounts. In determining the amount of the allowance, the Company makes judgments about the creditworthiness of customers based on ongoing credit evaluations and assesses current economic trends affecting its customers that might impact the level of credit losses in the future and result in different rates of bad debts than previously seen. The Company also considers its historical level of credit losses. As of March 31, 2019 and December 31, 2018, there was an allowance for doubtful accounts of $27,851 and $27,851 respectively.

During the three months ended March 31, 2019 and 2018 the Company recorded a bad debt expense of $0 and $0, respectively.

Inventory

Inventory is stated at the lower of cost or market value. Inventory is determined to be salable based on demand forecast within a specific time horizon, generally eighteen months or less. Inventory in excess of salable amounts and inventory which is considered obsolete based upon changes in existing technology is written off. At the point of recognition, a new lower cost basis for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in that new cost basis.

Property and Equipment

Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the useful life as follows:

Internal-use software		3 years
Equipment		3 to 5 years
Computer equipment		3 to 7 years
Furniture and fixtures		5 to 7 years
Leasehold improvements		Shorter of life of asset or lease

Accounting for Website Development Costs

The Company capitalizes certain external and internal costs, including internal payroll costs, incurred in connection with the development of its website. These costs are capitalized beginning when the Company has entered the application development stage and cease when the project is substantially complete and is ready for its intended use. The website development costs are amortized using the straight-line method over the estimated useful life of three years.

Impairment of Long-Lived Assets

Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of would be separately presented in the balance sheets and reported at the lower of the carrying amount or fair value less costs to sell, and no longer depreciated. The assets and liabilities of a disposed group classified as held for sale would be presented separately in the appropriate asset and liability sections of the balance sheets.

Debt Discount and Debt Issuance Costs

Debt discounts and debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense based on the related debt agreements using the straight-line method. Unamortized discounts are netted against long-term debt.

Derivative Liability

In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Paragraph 815-15-25-1 the conversion feature and certain other features are considered embedded derivative instruments, such as a conversion reset provision, a penalty provision and redemption option, which are to be recorded at their fair value as its fair value can be separated from the convertible note and its conversion is independent of the underlying note value. The Company records the resulting discount on debt related to the conversion features at initial transaction and amortizes the discount using the effective interest rate method over the life of the debt instruments. The conversion liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

The Company follows ASC Section 815-40-15 (“Section 815-40-15”) to determine whether an instrument (or an embedded feature) is indexed to the Company’s own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument’s contingent exercise and settlement provisions. The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.

The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.

The Company utilizes the binomial option pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The binomial option pricing model includes subjective input assumptions that can materially affect the fair value estimates. The expected volatility is estimated based on the most recent historical period of time equal to the remaining contractual term of the instrument granted.

Revenue Recognition

The Company adopted ASC 606 effective January 1, 2018 using the modified retrospective method which would require a cumulative effect adjustment for initially applying the new revenue standard as an adjustment to the opening balance of retained earnings and the comparative information would not require to be restated and continue to be reported under the accounting standards in effect for those periods.

Based on the Company’s analysis the Company did not identify a cumulative effect adjustment for initially applying the new revenue standards. The Company principally generates revenue through providing product, services and licensing revenue

The adoption of ASC 606 represents a change in accounting principle that will more closely align revenue recognition with the delivery of the Company’s services and will provide financial statement readers with enhanced disclosures. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. To achieve this core principle, the Company applies the following five steps:

1)	Identify the contract with a customer

A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.

2)	Identify the performance obligations in the contract

Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services, the Company must apply judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met the promised services are accounted for as a combined performance obligation.

3)	Determine the transaction price

The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring services to the customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company’s contracts as of December 31, 2018 contained a significant financing component. Determining the transaction price requires significant judgment, which is discussed by revenue category in further detail below.

4)	Allocate the transaction price to performance obligations in the contract

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series of distinct services that are substantially the same qualifies as a single performance obligation in a contract with variable consideration, the Company must determine if the variable consideration is attributable to the entire contract or to a specific part of the contract. For example, a bonus or penalty may be associated with one or more, but not all, distinct services promised in a series of distinct services that forms part of a single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that forms part of a single performance obligation. The Company determines standalone selling price based on the price at which the performance obligation is sold separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

5)	Recognize revenue when or as the Company satisfies a performance obligation

The Company satisfies performance obligations either over time or at a point in time. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised service to a customer.

	Three Months ended March 31, 2019						Three Months ended March 31, 2018
	United States		International		Total		United States		International		Total
Product Revenue		494		757		1,251		39,666		27,178		66,844
Product Service Revenue		288		-		288		3,468		1,987		5,455
Licensing Revenue		-		-		-		4,130				4,130
		782		757		1,539		47,264		29,165		76,429

Product revenue

Revenue from multiple-element arrangements is allocated among separate elements based on their estimated sales prices, provided the elements have value on a stand-alone basis.

Licensing revenue

Some of the Company’s revenues are generated from software-as-a-service (“SaaS”) subscription offerings and related product support and maintenance. SaaS revenues stem mainly from annual subscriptions and are recorded evenly over the term of the subscription. Any customer payments received in advance are deferred until they are earned. Consulting and training revenues are recognized as work is performed.

Warranty

The Company provides a limited warranty for its analyzers and sensors for a period of 1 year from the date of shipment that such goods will be free from material defects in material and workmanship. The Company has assessed the historical claims and, to date, warranty claims have not been significant. The Company will continue to assess the need to record a warranty accrual at the time of sale going forward.

Product Returns

For any product in its original, undamaged and unmarked condition, with its included accessories and packaging along with the original receipt (or gift receipt) within 30 days of the date the customer receives the product, the Company will exchange it or offer a refund based upon the original payment method.

Customer Deposits

The Company accounts for funds received from crowdfunding campaigns and pre-sales as a liability on the consolidated balance sheets as the investments made entitle the investor to apply these funds towards future shipments once the product has been developed and available for commercial use.

Research and Development Costs

Research and development costs are charged to expense as incurred. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased materials and services provided by independent contractors, software developed by other companies and incorporated into or used in the development of our final products. Research and development expenses for the three months ended March 31, 2019 and 2018 were $13,935 and $233,090, respectively.

Advertising Costs

Advertising costs are charged to sales and marketing expenses and general and administrative expenses as incurred. Advertising expenses, which are recorded in sales and marketing and general and administrative expenses, totaled $54,290 and $37,253 for the three months ended March 31, 2019 and 2018, respectively.

Stock-Based Compensation

The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation – Stock Compensation” (“ASC 718”) which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value-based method of accounting for an employee stock option or similar equity instrument. Accordingly, stock-based compensation is recognized in the consolidated statements of operations as an operating expense over the requisite service period. The Company uses the Black-Scholes option pricing model adjusted for the estimated forfeiture rate for the respective grant to determine the estimated fair value of stock-based compensation arrangements on the date of grant and expenses this value ratably over the requisite service period of the stock option. The Black-Scholes option pricing model requires the input of highly subjective assumptions. Because the Company’s stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management’s opinion, the existing models may not provide a reliable single measure of the fair value of the Company’s stock options. In addition, management will continue to assess the assumptions and methodologies used to calculate estimated fair value of stock-based compensation. Circumstances may change and additional data may become available over time, which could result in changes to these assumptions and methodologies for future grants, and which could materially impact the Company’s fair value determination.

Collaborative Arrangements

The Company and its collaborative partners are active participants in the collaborative arrangements and both parties are exposed to significant risks and rewards depending on the commercial success of the activity. The Company records all expenses related to collaborative arrangements as research and development expense in the consolidated statements of operations as incurred.

Earnings per Share

Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents.

The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income (loss) attributable to common stockholders per common share.

	For the Three Months Ended
	March 31, 2019			March 31, 2018
Numerator:
Net income/(loss) attributable to common stockholders	$	294,370		$	879,905
Effect of dilutive securities:		-			-
Convertible note - Interest Expense		20,241			8,751
Change in Warrant liability		(815,970	)		-
Net Change in derivative liabilities - convertible payables		(135,244	)		(1,365,055	)

Diluted net income (loss)	$	(636,603	)	$	(476,399	)

Denominator:
Weighted average common shares outstanding - basic		4,043,156,414			1,878,730,874
Dilutive securities (a):
Series A Preferred		51			51
Series B Preferred		1,070,000,000			2,967,000,000
Convertible notes payable		738,212,072			128,586,957
Convertible accounts payable		330,000,000			346,554,654
Options		-			-
Warrants		1,615,879,300			-

Weighted average common shares outstanding and assumed conversion - diluted		7,797,250,837			5,320,872,536

Basic net income (loss) per common share	$	0.00		$	0.00

Diluted net loss per common share	$	(0.00	)	$	(0.00	)

(a) - Anti-dilutive securities excluded:		9,067,645			261,835,149

Recent Accounting Guidance Adopted

In February 2016, the FASB issued ASU 2016-02 “Leases” (Topic 842) which amended guidance for lease arrangements to increase transparency and comparability by providing additional information to users of financial statements regarding an entity’s leasing activities. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as ASC 842. The revised guidance seeks to achieve this objective by requiring reporting entities to recognize lease assets and lease liabilities on the balance sheet for substantially all lease arrangements.

On January 1, 2019, the Company adopted ASC 842 using the modified retrospective approach. Results for the three months ended March 31, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the legacy accounting guidance under ASC Topic 840, Leases.

As part of the adoption we elected the practical expedients permitted under the transition guidance within the new standard, which among other things, allowed us to:

	1.	Continue applying our current policy for accounting for land easements that existed as of, or expired before, January 1, 2019.

	2.	Not separate non-lease components from lease components and instead to account for each separate lease component and the non-lease components associated with that lease component as a single lease component.

	3.	Not to apply the recognition requirements in ASC 842 to short-term leases.

	4.	Not record a right of use asset or right of use liability for leases with an asset or liability balance that would be considered immaterial.

5.	Inventory

Inventory as of March 31, 2019 and December 31, 2018 is as follows:

	March 31,		December 31,
	2019		2018
Finished goods	$	7,511	$	9,781
Raw materials		150,445		104,250
	$	157,956	$	114,031

Debt

Convertible Notes

The following table shows the outstanding balance as of March 31, 2019 and December 31, 2018 respectively.

	March 31,			December 31,
	2019			2018
Convertible Note - February 6, 2017		265,750			265,750
Convertible Note - July 23, 2018		25,000			25,000
Convertible Note – October 1, 2018		74,800			74,800
Convertible Note – October 4, 2018		73,500			73,500
Convertible Note – October 11, 2018		283,500			283,500
Convertible Note – December 19, 2018		82,000			82,000
Convertible Note – March 7, 2019		210,000			-
		1,014,550			804,550
Less: Debt Discount		(419,051	)		(368,373	)
Total	$	595,499		$	436,177

Amendment 2

On December 27, 2017 the Company, Hasfer, Inc. and Legacy, entered into an amendment to the note. The note was modified as follows:

●	A portion of the outstanding principal and interest was assigned to Legacy.

●	The company received proceeds of $48,500.

●	Fees related to the amendment totaled $1,500. The fees were recorded as a loss on extinguishment of debt.

All remaining terms of the Revolving note remained the same.

In accordance with ASC 470, since the present value of the cash flows under the new debt instrument was at least ten percent different from the present value of the remaining cash flows under the terms of the original debt instrument, the Company accounted for the amendment to SPA as a debt extinguishment. Accordingly, the Company recorded a loss on extinguishment of debt of $155,086.

During the year ended December 31, 2017 Hasfer converted $236,250 of the outstanding principal into 99,891,304 share of the company’s common stock.

As of December 31, 2017 and 2016 the balance of this agreement was $295,750 and $0 respectively.

During the year ended December 31, 2018 Hasfer, Inc and Carte Blanche, LLC entered into a note purchase agreement. Hasfer assigned $60,000 to Carte Blanche, LLC. The Company received additional proceeds of $30,000.

During the year ended the lenders converted $60,000 of the outstanding principal into 26,086,956 shares of the Company’s common stock.

On July 23, 2018 the Company issued convertible notes to third party lenders totaling $25,000. These notes accrue interest at a rate of 12% per annum and mature with interest and principal due July 23, 2019. The note and accrued interest are convertible at a conversion price equal to a 30% discount of the Company’s common stock prior day close price.

Due to the fact that these convertible notes have an option to convert at a variable amount, they are subject to derivative liability treatment. The Company has applied ASC 815, due to the potential for settlement in a variable quantity of shares. The conversion feature has been measured at fair value using a Binomial Option Pricing model at the issuance date and the period end. The conversion feature of the convertible note gave rise to a derivative liability of $19,070 which was recorded as a debt discount. The debt discount is charged to other expense ratably over the term of the convertible note

On July 23, 2018 the Company issued convertible notes to third party lenders totaling $25,000. The note accrues interest at a rate of 12% per annum and mature with interest and principal due July 23, 2019. The note and accrued interest are convertible at a conversion price equal to a 30% discount of the Company’s common stock prior day close price.

Geneva Securities Purchase Agreement

Effective October 1, 2018, the Company entered into a securities purchase agreement (the “Geneva Purchase Agreement”) with Geneva Roth Remark Holdings, Inc., (“Geneva”), pursuant to which Geneva purchased a 10% unsecured convertible promissory note (the “Geneva Note”) from the Company in the aggregate principal amount of $74,800, such principal and the interest thereon convertible into shares of the Company’s common stock at the option of Geneva.

The purchase price of $74,800 of the Geneva Note was paid in cash by Geneva on October 2, 2018. After payment of transaction-related expenses, net proceeds to the Company from the Geneva Note totaled $65,000.

The maturity date of the Geneva Note is October 1, 2019 (the “Geneva Maturity Date”). The Geneva Note shall bear interest at a rate of ten percent (10%) per annum (the “Geneva Interest Rate”), which interest shall be paid by the Company to Geneva in shares of common stock at any time Geneva sends a notice of conversion to the Company. Geneva is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the Geneva Note into shares of the Company’s common stock, at any time after March 20, 2019, at a conversion price for each share of common stock equal to 71% multiplied by the average of the lowest three (3) trading prices (as defined in the Geneva Purchase Agreement) for the common stock during the fifteen (15) Trading Day period (as defined in the Geneva Purchase Agreement) ending on the latest complete trading day prior to the conversion date.

The Geneva Note may be prepaid until 170 days from the issuance date in accordance with its terms.

The Company shall reserve 270,905,432 of its authorized and unissued common stock (the “Geneva Reserved Amount”), free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of the Geneva Note.

GS Capital Securities Purchase Agreement

Effective October 4, 2018 the Company entered into a securities purchase agreement (the “GSC Purchase Agreement”) with GS Capital Partners LLC, (“GSC”, and together with Geneva, the “Investors”), pursuant to which GSC purchased a 8% unsecured convertible promissory note from the Company in the aggregate principal amount of $75,000 (the “GSC Note”), such principal and the interest thereon convertible into shares of the Company’s common stock at the option of GSC.

The purchase price of $75,000 of the GSC Note was paid in cash by GSC on October 5, 2018. After payment of transaction-related expenses, net proceeds to the Company from the First GSC Note totaled $68,500.

The maturity date of the GSC Note is October 4, 2019 (the “the GSC Maturity Date”). The GSC Note shall bear interest at a rate of eight percent (8%) per annum (the “GSC Interest Rate”), which interest shall be paid by the Company to GSC in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company’s common stock, at any time, at the conversion price specified in the for each share of common stock equal to 71% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note the Company recorded a $58,855 debt discount.

The GSC Note may be prepaid until 180 days from the issuance date in accordance with its terms.

The Company shall reserve 211,267,000 of its authorized and unissued common stock (the “GSC Reserved Amount”), free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of the GSC Note.

Eagle and GSC Securities Purchase Agreements

Effective October 11, 2018, the Company entered into a securities purchase agreement (the “Eagle Purchase Agreement”) with Eagle Equities, LLC (“Eagle”), pursuant to which Eagle purchased an 8% unsecured convertible promissory note (the “Eagle Note”) from the Company in the aggregate principal amount of $181,500, such principal and the interest thereon convertible into shares of the Company’s common stock at the option of Eagle.

Effective October 11, 2018 the Company entered into a securities purchase agreement (the “GSC Purchase Agreement” and together with the Eagle Purchase Agreement, the “SPAs”) with GSC (together with Eagle, the “Investors”), pursuant to which GSC purchased an 8% unsecured convertible promissory note (the “GSC Note” and together with the Eagle Note, the “Notes”) from the Company in the aggregate principal amount of $102,000, such principal and the interest thereon convertible into shares of the Company’s common stock at the option of GSC.

The maturity date of the Notes is October 11, 2019 (the “Maturity Date”). The Notes shall bear interest at a rate of eight percent (8%) per annum (the “Interest Rate”), which interest shall be paid by the Company to the Investors in shares of common stock at any time Eagle or GSC sends a notice of conversion to the Company (the “Notice of Conversion”). The Investors are entitled to, at their option, convert all or any amount of the principal face amount and any accrued but unpaid interest of their respective Notes into shares of the Company’s common stock, at any time, at a conversion price for each share of common stock equal to 65% multiplied by the lowest closing bid price of the common stock as reported on the marketplace upon which the Company’s shares are traded during the fifteen (15) trading day period ending on the day upon which a Notice of Conversion is received by the Company. In connection with this note, the Company recorded a $149,702 and $85,085 debt discounts.

The Notes may be prepaid until 180 days from the issuance date in accordance with its terms.

The Company shall reserve 532,000,000, and 299,000,000, of its authorized and unissued common stock free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of the Eagle Note (the “Eagle Reserved Amount”), and the GSC Note (the “GSC Reserved Amount” and together with the Eagle Reserved Amount, the “Total Reserved Amount”), respectively.

Effective December 19, 2018 the Company entered into a securities purchase agreement (the “GSC Purchase Agreement”) with GS Capital Partners LLC, (“GSC”, and together with Geneva, the “Investors”), pursuant to which GSC purchased a 8% unsecured convertible promissory note from the Company in the aggregate principal amount of $82,000 (the “GSC Note”), such principal and the interest thereon convertible into shares of the Company’s common stock at the option of GSC.

The purchase price of $82,000 of the GSC Note was paid in cash by GSC on December 19, 2018. After payment of transaction-related expenses, net proceeds to the Company from the First GSC Note totaled $76,000.

The maturity date of the GSC Note is December 19, 2019 (the “the GSC Maturity Date”). The GSC Note shall bear interest at a rate of eight percent (8%) per annum (the “GSC Interest Rate”), which interest shall be paid by the Company to GSC in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company’s common stock, at any time, at the conversion price specified in the for each share of common stock equal to 67% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note, the Company recorded a $76,000 debt discount.

The GSC Note may be prepaid until 180 days from the issuance date in accordance with its terms.

GS Capital Agreement

The purchase price of $210,000 of the GS Capital note was paid in cash by GS Capital on March 11, 2019. After payment of transaction-related expenses, net proceeds to the Company from the note totaled $200,000.

The maturity date of the GS Capital note is March 7, 2020. The GS Capital Note shall bear interest at a rate of eight percent (8%) per annum which interest shall be paid by the Company to GS Capital in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company’s common stock, at any time, at the conversion price specified in the for each share of common stock equal to 65% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note, the Company recorded a $167,296 debt discount.

7.	Derivative Liabilities

The Company has identified derivative instruments arising from embedded conversion features in the Company’s convertible notes payable and accounts payable at March 31, 2019.

The following summarizes the Binomial-lattice model assumptions used to estimate the fair value of the derivative liability and warrant liability at the date of issuance and for the convertible notes converted during the three months ended March 31, 2019.

	Low			High
Annual dividend rate		0	%		0	%
Expected life in years		.32			1.00
Risk-free interest rate		2.40	%		2.44	%
Expected volatility		103	%		114	%

Risk-free interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar term on the date of the grant.

Dividend yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future.

Volatility: The volatility was estimated using the historical volatilities of the Company’s common stock.

Remaining term: The Company’s remaining term is based on the remaining contractual maturity of the convertible notes payable and accounts payable.

The following are the changes in the derivative liabilities during the three months ended March 31, 2019.

Three Months Ended March 31, 2019

Level 1

Level 2

Level 3

Derivative Liability as of January 1, 2019

1,222,186

Initial derivative expense

166,790

Gain on changes in fair value

(135,244

)

Derivative liabilities as of March 31, 2019

1,253,732

The following are the changes in the warrant liabilities during the three months ended March 31, 2019.

	Three Months Ended March 31, 2019
	Level 1		Level 2		Level 3
Balance, January 1, 2019	$	-	$	-	$	6,267,426
Change due to exercise of warrants						(845,883	)
Gain on changes in fair value		-		-		(815,970	)
Accretion of warrant expense		-		-		245,775
Warrant liabilities as March 31, 2019	$	-	$	-	$	4,851,348

8.	Stockholders’ Deficit

Preferred Stock

On September 30, 2016, the Company filed a Certificate of Amendment to Articles of Incorporation with the Secretary of State of the State of Nevada to authorize for issuance ten million (10,000,000) shares of blank check preferred stock, par value $0.001 (“Blank Check Preferred Stock”) as included on Form 8-K filed with the SEC on October 4, 2016.

Series A Preferred Stock

As of March 31, 2019, and March 31, 2018, the Company has designated 51 shares of Series A Preferred Stock par value $0.001 and 51 shares are issued and outstanding. The Series A Preferred Stock can convert into common stock at a 1:1 ratio. Each one (1) share of the Series A Preferred shall have voting rights equal to (x) 0.019607 multiplied by the total issued and outstanding shares of Common Stock eligible to vote at the time of the respective vote (the “Numerator”), divided by (y) 0.49, minus (z) the Numerator. For purposes of illustration only, if the total issued and outstanding shares of Common Stock eligible to vote at the time of the respective vote is 5,000,000, the voting rights of one share of the Series A Preferred Stock shall be equal to 102,036 (0.019607 x 5,000,000) / 0.49) – (0.019607 x 5,000,000) = 102,036). On December 23, 2016 the 51 shares were issued to Mr. Yazbeck, the Company’s sole officer and the sole member of the Board. Mr. Yazbeck, via his ownership of the 51 shares of the Series A Preferred, has control of the majority of the Company’s voting stock.

Series B Preferred Stock

The Series B Preferred is convertible into shares of Common Stock at a conversion price of $0.0001. Holders of the Series B Preferred are entitled to receive dividends annually equal to $0.10 for each share of Series B Preferred held. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series B Preferred then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders, before any payment shall be made to the holders of Common Stock. Until such time as there are fewer than 20,000 shares of Series B Preferred outstanding, the Company needs to obtain the majority votes of the holders of Series B Preferred with regard to certain actions. Holders of Series B Preferred shares are entitled to one vote for each share held, are entitled to elect up to two members to the Board, and, absent such election, are provided certain voting and veto rights with regard to any vote by the Board.

On July 31, 2018, the Company agreed to eventually issue 38,272 shares of Series B Preferred at a value of $1.00 per Series B Preferred share to settle outstanding vendor liability. The shares of Series B Preferred will be issued upon an increase in the authorized shares of Series B Preferred. The Company also agreed to the assignment or issuance of three warrants giving the holder the right to purchase seven and one half percent (7.5%) of the Company’s shares of Common Stock issued and outstanding at the time of exercise and having an exercise price of $0.001 per share. This form of warrant is referred to herein as the “7.5% Warrant.” The Company agreed to the assignment of one previously issued 7.5% Warrant to an entity related to BCI Advisors. This 7.5% Warrant will expire on July 31, 2020. In addition, the Company also agreed to the assignment of another previously issued 7.5% Warrant to an entity related to BCI Advisors and agreed to extend the expiration date from March 1, 2019 to July 31, 2020. Finally, the Company agreed to issue a new 7.5% Warrant which will expire on July 31, 2020. The Company currently does not have enough authorized shares to issue the Series B Preferred shares and therefore, have recorded them as a liability at their fair value of $1,262,976.

On July 30, 2018, the Company agreed to eventually issue 45,355 shares of the Company’s Series B Preferred at a value of $1.00 per Series B Preferred share to settle outstanding vendor liability. The Company also agreed to issue a 7.5% Warrant with an expiration date of July 31, 2020. The Company currently does not have enough authorized shares to issue the Series B shares and therefore, have recorded them as a liability at their fair value of $1,587,425.

During the year ended December 31, 2018 investors converted 189,700 Series B Preferred stock in to 1,897,000,000 shares of common stock.

Common Stock

On September 30, 2016, the Company amended articles of incorporation to increase the number of authorized commons shares to 10,000,000,000 as included on Form 8-K filed with the SEC on October 4, 2016.

On January 15, 2019, the Company issued 165,546,562 shares of common stock for a cashless exercise on warrants.

9.	Commitments and Contingencies

Distribution and License Agreement and Joint Development Agreements

The Company entered into a Distribution and License Agreement with a third-party for the purpose of developing a sensor array to be used in the Company’s product. The Distribution and License Agreement has an initial term of ten years, but can be terminated earlier if the project does not meet the specifications of the Company. The Company will obtain exclusive rights to sell and distribute once a successful sensor prototype is developed. In exchange for a functional prototype, the Company will pay the third-party a 7% royalty on net sales. During the three months ended March 31, 2019, the Company did not incur any development costs related to the Distribution and License Agreement.

On November 1, 2013, the Company entered into a two-year Joint Development Agreement (the “Agreement”) with an unrelated third-party to develop chemical sensors and peripheral sensing equipment and software for the detection and characterization of cannabis and compounds associated with cannabis.

The Agreement provides for, among other things, any arising intellectual property rights (as defined) outside of the field (as defined), and any arising intellectual property rights relating to improvements to detection materials shall belong to the Joint Venture Developer.

The Agreement also provides that any arising intellectual property rights other than those covered above shall belong to the Company. To the extent that it is necessary to do so to enable the Company to use and exploit its respective arising intellectual property rights, the Joint Developer grants the Company a perpetual, irrevocable, exclusive, and royalty free license (including the right to assign the license and to grant sub-licenses) to use and exploit the Joint Developer’s arising intellectual property rights in the field. Under the terms of the Agreement, either party may cancel the Agreement as the specific tasks provided for in the Agreement have been completed or for causes specifically provided for in the Agreement.

On May 19, 2015, the Company entered into an Exclusive Patent Sublicense Agreement (the “License Agreement”) with Next Dimension Technologies, Inc. (“NDT”). The License Agreement grants the Company a worldwide right to the patents licensed by NDT from the California Institute of Technology. The License Agreement grants both exclusive and non-exclusive patent rights. The license granted in the License Agreement permits the Company to make, have made, use, sell and offer for sale sublicensed products in the field of use. The License Agreement continues until the expiration, revocation, invalidation or enforceability of the rights licensed. The License Agreement provides for the payment of a license fee and royalty payments by CDx to NDT. The License Agreement also contains minimum royalty payments and milestone payments by CDx to NDT. NDT has a right to terminate the License Agreement in the event of an uncured breach by CDx; the insolvency or bankruptcy of CDx; or if CDx does not meet certain productivity milestones. The License Agreement also contains representations, warranties and indemnity obligations for each of CDx and NDT. In connection with the License Agreement, on May 19, 2015, CDx and NDT also executed an Amended Amendment No. 4 (the “Amended Amendment No. 4”) to the Joint Development Agreement, dated as of November 1, 2013, between CDx and NDT, which extended the date of negotiation for the License Agreement through May 19, 2015.

Litigation

In the normal course of business, the Company may be subject to other legal proceedings, lawsuits and other claims. Although the ultimate aggregate amount of probable monetary liability or financial impact with respect to these matters is subject to many uncertainties and is therefore not predictable with assurance, the Company’s management believes that any monetary liability or financial impact to the Company from these other matters, individually and in the aggregate, would not be material to the Company’s financial condition, results of operations or cash flows.

However, there can be no assurance with respect to such result, and monetary liability or financial impact to the Company from these other matters could differ materially from those projected.

10.

Subsequent Events

LG Note

On May 2, 2019, the Company entered into a securities purchase agreement with LG Capital Funding, LLC (“LG Capital”) for the sale of two 8% convertible redeemable notes in the original principal amount of $63,945, or an aggregate principal amount of $127,890 (the “LG Note”), which included an aggregate payment of $126,000 to the Company at an original issue discount of $1,890.

The LG Note bears interest at the rate of 8% per annum. All interest and principal must be repaid on May 2, 2020. The LG Note is convertible into common stock at any time after the six-month anniversary of the LG Note, at LG Capital’s option, at a price equal to 65% of the average of the two lowest closing trading prices of the common stock during the fifteen-day period prior to conversion. The LG Note may not be prepaid more than 180 days prior to its maturity date. In the event the Company prepays the LG Note in full during the 180 days prior to its maturity date, the Company must pay off all principal, interest and any other amounts owing multiplied by a premium ranging from 5% to 30%.

LG Capital has agreed to restrict its ability to convert the LG Note and receive shares of common stock such that the number of shares of common stock held by them in the aggregate and their affiliates after such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of common stock. The LG Note is a debt obligation arising other than in the ordinary course of business which constitutes a direct financial obligation of the Company.

The LG Note contains default events which, if triggered and not timely cured (if curable) by the Company, will result in the option by LG Capital to consider the LG Note immediately due and payable, without presentment, demand, protest or (further) notice of any kind (other than notice of acceleration). Upon an event of default, interest shall accrue at a default interest rate of 24% per annum or, if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.

The LG Note was offered and sold to LG Capital in a private placement transaction made in reliance upon exemptions from registration pursuant to Section 4(a)(2) under the Securities Act of 1933 (the “Securities Act”) and/or Rule 506 promulgated under the Securities Act. LG Capital is an accredited investor as defined in Rule 501 of Regulation D promulgated under the Securities Act.

Odyssey Note

On May 7, 2019, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Odyssey Capital Funding, LLC (“Odyssey”) for the sale of an 12% convertible redeemable note in the amount of $100,000 (the “Odyssey Note”).

The Odyssey Note bears interest at the rate of 12% per annum. All interest and principal must be repaid on May 7, 2020. The Odyssey Note is convertible into common stock at any time after the six-month anniversary of the Odyssey Note, at Odyssey’s option, at a price equal to 60% of the lowest closing trading price of the common stock during the twenty day period prior to conversion. The Odyssey Note may not be prepaid more than 180 days prior to its maturity date. In the event the Company prepays the Note in full during the 180 days prior to its maturity date, the Company must pay off all principal, interest and any other amounts owing multiplied by a premium ranging from 25% to 45%.

Odyssey has agreed to restrict its ability to convert the Odyssey Note and receive shares of common stock such that the number of shares of common stock held by them in the aggregate and their affiliates after such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of common stock. The Odyssey Note is a debt obligation arising other than in the ordinary course of business which constitute a direct financial obligation of the Company.

The Odyssey Note contains default events which, if triggered and not timely cured (if curable) by the Company, will result in the option by Odyssey to consider the Odyssey Note immediately due and payable, without presentment, demand, protest or (further) notice of any kind (other than notice of acceleration). Upon an Event of Default, interest shall accrue at a default interest rate of 24% per annum or, if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.

The Odyssey Note was offered and sold to Odyssey in a private placement transaction made in reliance upon exemptions from registration pursuant to Section 4(a)(2) under the Securities Act of 1933 (the “Securities Act”) and/or Rule 506 promulgated under the Securities Act. Odyssey is an accredited investor as defined in Rule 501 of Regulation D promulgated under the Securities Act.

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATIONS

The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, MyDx’s audited annual financial statements and the related notes thereto as filed with the Securities and Exchange Commission (“SEC”) on April 24, 2019. This discussion contains certain forward-looking statements that involve risks and uncertainties, as described under the heading “Forward-Looking Statements” in this quarterly report. Actual results could differ materially from those projected in the forward-looking statements. For additional information regarding these risks and uncertainties, please see the disclosure under the heading “Risk Factors” elsewhere in this quarterly report.

We believe that our assumptions are based upon reasonable data derived from and known about our business and operations and the business and operations of the Company. No assurances are made that actual results of operations or the results of our future activities will not differ materially from its assumptions. Factors that could cause differences include, but are not limited to, expected market demand for the Company’s products and services and competition.

Overview

MyDx is a science and technology company that develops and deploys products and services in the following focus areas:

Consumer Products – smart devices and consumables

Data Analytics – pre-clinical chemical analysis and patient feedback ecosystem

Biopharmaceuticals – identifying ‘green Active Pharmaceutical Ingredients^TM, (gAPI^TM) and corresponding formulations

Software as a Service (SaaS) – Software services for prescribers, patient groups, cultivators, and regulators

We are committed to addressing areas of critical national need to promote public safety, transparency and regulation in the various markets we serve.

The Company’s first product, MyDx^®, also known as “My Diagnostic”, is a multiuse hand-held chemical analyzer made for consumers and professional users which feeds our data analytics platform and SaaS business. MyDx is intended to allow consumers to Trust & Verify^® what they put into their mind and body by using our science and technology to test for pesticides in food, chemicals in water, toxins in the air, and the safety and potency of cannabis samples, which is our initial focus.

Business Plan

The Company is currently focused on 4 key business segments to service the cannabis industry.

1.	Consumer Products

Smart Devices & Consumables

CannaDx^TM

	●	The cannabis industry’s first hand-held cannabis sensor and analyzer with disposable single use inserts.
	●	Comes with a mobile app that acts as a ‘virtual budtender’.
	●	Analyzes cannabis sample and provides a Total Canna Profile^TM (TCP), a more complete chemical profile to include THC and the most prevalent cannabinoids and terpenes found in cannabis plants.
	●	Cannabinoids such as THC and CBD have been reported to bind the CB1 and CB2 receptors found throughout the human body and have been reported to provide relief to an array of symptoms, including pain, nausea, and inflammation to name a few. Terpenes, which have been reported to compound the effects of cannabinoids on the body via an “Entourage Effect”, are also important in determining the overall physiological effects various cannabis chemical profiles.
	●	Enables users to log their ailments and side effects and tie those back to the exact chemical profile.
	●	Provides strain recommendations based on desired “relief” input based on crowdsourced community feedback.

Eco Smart Pen^TM and Other Delivery Devices

	●	MyDx plans to develop additional smart hardware that gather user data, such as the Eco Smart Pen. MyDx plans to release the Eco Smart Pen in the first quarter of 2019.
	●	Integrated with Bluetooth as well as other technologies that will allow for mobile-app control, dose restrictions, safety controls, and usage statistics.
	●	We plan to OEM these product to third-party customers.

MyDx Tablet Edition

	●	MyDx plans to develop he first touchscreen kitchen tablet in the market with integrated MyDx sensor reading capability.
	●	Sensor lineup to include OrganaDx, AquaDx, and AeroDx.
	●	Company plans to offer CannaDx data portal management ability in MyDx Tablet Edition.

MyDx plans to evaluate the 510K FDA device approval process to leverage its consumer products and the ability of insurance companies to support sales of its smart devices and generate HIPPA compliant crowdsourced data.

2.	Data Analytics

Pre-Clinical Chemical Analysis and Patient Feedback Ecosystem.

MyDx has four classes of data and algorithms:

User Data

●

When users download the CannaDx mobile app, we may ask them put in personal details such as gender, location, height, weight, age etc. that we maintain while complying with HIPAA.

Chemical Composition Data

●

This information is sourced from a number of inputs including the CannaDx Handheld’s Total Canna Profile (TCP), partner laboratories analyses, and branded pre-tested concentrates.

User Feedback

●

Provided by users in our CannaDx mobile app as they try various products and record their experiences with those products.

Usage Statistics

●

We plan to capture type, frequency, dosage, ailments relieved, and side effects.

MyDx plans to leverage this data, which combined is referred to as the Total Canna Profile^TM (TCP), combined with our proprietary algorithms, to develop key insights into user behavior based on unique chemical profiles. Our goal is to track how a specific sample is expected to help relieve certain ailments and to validate the results.

3.	Biopharmaceutical

Identifying ‘green Active Pharmaceutical Ingredients^TM’ (gAPI^TM) and corresponding formulations

Sale and License of Product Formulations

●

MyDx plans to work with third party customers to license crowdsourced formulated chemical profiles that are expected to address a specific “relief” desired using its own proprietary formulas derived from our extensive dataset and algorithms.

Sale of green Active Pharmaceutical Ingredients (gAPI^TM)

	●	This division will also look to provide an organic source of extracted green Active Pharmaceutical Ingredients (gAPI^TM), such as a predefined terpene formulation, for consumer and industrial use.
	●	Given that certain classes of gAPI’s such hemp derived CBD and terpenes might offer “relief” without the “high” THC provides, MyDx intends to partner with leaders in the industry to offer branded products without THC, akin to a “virgin” cocktail, if it finds that these formulations offer the benefits desired and the legal framework to sell them is viable.

4.	SaaS (Software as a Service)

Software services for prescribers, patient groups, cultivators, and regulators

MyDx App

	●	Available in iOS and Android and controls the MyDx Analyzer.
	●	Tracks patient tested samples and physiological feedback.
	●	Prints a Certificate of Analysis, which includes patient feedback.
	●	Offers patients groups and their doctors with OEM software to track what the community is experiencing.
	●	Centrally hosted in our secure cloud based server.
	●	Will offer in App purchases for additional software subscription features.

MYDX360

	●	MyDx360 is a Software As A Service (SAAS)-based community engagement platform designed to help entrepreneurs develop, launch and track the effects of new formulated products on consumers to help penetrate their target markets more effectively.
	●	As part of the service, companies will choose from among MyDx’s many chemical formulations that best align with the physiological response its target demographic is seeking. From there, MyDx will outsource the delivery of those formulations through licensed concentrate manufacturing facilities and provide customer-engagement support via its SAAS platform and MyDx smart devices such as the EcoSmartPen to acquire and analyze user feedback.
	●	Collectively, this suite of services will be called MyDx360.

Software to Support Laboratory Marketing, Customer Service and Data Aggregation

	●	MyDx will offer what we believe will be the premier lead generator and outsourced services provider for cannabis testing labs.
	●	Through certain assets MyDx expects to develop or acquire, as well as leads generated from our handheld analysis and smart devices, we believe MyDx will be positioned to become a world leader in cannabis laboratory marketing and services and as the largest “data holder” of tested cannabis and the associated chemical profiles tied to the ailment therapy.

Results of Operations

As shown in the accompanying consolidated financial statements, the Company realized net income of $305,070 and net income of $879,905, respectively, for the three months March 31, 2019 and March 31, 2018. The Company had an accumulated deficit of $39,670,860 and $39,965,231 respectively, as of March 31, 2019 and December 31, 2018.

Comparison of The Three Months Ended March 31, 2019 and 2018

Revenue

For the three months ended March 31, 2019 and 2018, the Company had licensing revenue of $0 and $4,130, respectively. For the three months ended March 31, 2019 and 2018, the Company had product revenue of $1,251 and $66,844 respectively. The decrease in revenue for the three months ended March 31, 2019 compared to 2018 was a result of a backlog of products not being shipped out. Due to a supply chain disruption, MyDx was unable to deliver finished units in the first quarter of 2019. These issues have since been resolved and deliveries are expected to resume in the beginning of the third quarter.

Cost of Goods Sold and Gross Profit

Gross profit as a percentage of net revenues for the three months ended March 31, 2019 and 2018 were (998%) and 75%, respectively. During the three months ended March 31, 2019 the Company had $1,200 in revenue and $16,883 in costs of goods sold. The Company has fixed costs of $15,000 that is contributing to the high cost of goods sold.

Operating Expenses

For the three months ended March 31, 2019, the Company incurred operating expenses in the amount of $495,147 compared to $530,990 for the three months ended March 31, 2018. These operating expenses were composed of research and development costs, sales and marketing and general and administrative expenses. The decrease mainly resulted from the decrease in research and development which were partially offset by the increase in sales and marketing and general and administrative expenses.

Research and Development Expenses

Research and development expenses primarily consist of engineering and product development, incurred in the design, development, testing and enhancement of our products. For the three months ended March 31, 2019, the Company expended $13,935 for various research and development projects for hardware, database, software and sensor development as compared to $233,090 for the three months ended March 31, 2018. The decrease of $219,155, or 94%, resulted primarily from the Company decreasing its research and development efforts.

Sales and Marketing Expenses

Sales and marketing expenses consist primarily of consulting fees for third-party services and general marketing expenses. For the three months ended March 31, 2019, the Company expended $54,290 as compared to $52,253 for the three months ended March 31, 2018. The increase of $2,037, or 4 %, resulted primarily from the Company resulted primarily from the Company increasing marketing efforts.

General and Administrative Expenses

General and administrative expenses consist primarily of salaries, wages and benefits, consulting fees, legal fees, accounting fees and general administrative expenses.

For the three months ended March 31, 2019, the Company expended $426,922 as compared to $245,647 for the three months ended March 31, 2018. The increase of $181,275, or 73.8%, resulted primarily from an increase in stock- based compensation and professional fees.

Other income (expense)

Other income decreased by $555,943, resulted primarily from a decrease in change in fair value of derivative liability. This was offset by an increase in derivative expense and change in fair value of warrant liability.

Liquidity and Capital Resources

Since its inception, capital raised by the Company has been used primarily for the Company’s research and development efforts and to support its operations. As of March 31, 2019, the Company had remaining cash of $175,504 with a net working capital deficit of $11,280,134. As a result of the Company’s significant operating expenditures and the lack of significant product sales revenue, we expect to incur losses from operations for the near future and will be required to seek additional capital to sustain our operations.

It is anticipated that we will continue to report negative operating cash flow in future periods, likely until one or more of our products generate sufficient revenue to cover our operating expenses. If any of the warrants are exercised, all net proceeds of the warrant exercise will be used for working capital to fund negative operating cash flow.

Our cash balance of $175,504 will not be sufficient to fund our operations for at least the next 12 months. Additionally, if we are unable to generate sufficient revenues to pay our expenses, we will need to raise additional funds to continue our operations. We have historically financed our operations through private equity and debt financings. We do not have any commitments for financing at this time, and financing may not be available to us on favorable terms, if at all. If we are unable to obtain debt or equity financing in amounts sufficient to fund our operations, if necessary, we will be forced to suspend or curtail our operations. In that event, current stockholders would likely experience a loss of most or all their investment. Additional funding that we do obtain may be dilutive to the interests of existing stockholders.

To the extent, we raise additional capital by issuing equity securities or obtaining borrowings convertible into equity, ownership dilution to existing stockholders will result and future investors may be granted rights superior to those of existing stockholders. The incurrence of indebtedness or debt financing would result in increased fixed obligations and could also result in covenants that would restrict our operations. Our ability to obtain additional capital may depend on prevailing economic conditions and financial, business and other factors beyond our control. The Company cannot provide any assurances that it will be able to raise the additional capital needed to fund its operations, or if the Company is able to raise such additional capital, that any such financing will be on terms which are beneficial to the existing shareholders.

Working Capital

	March 31, 2019			December 31, 2018
Current assets	$	333,460		$	216,729
Current liabilities		11,613,594			12,643,275
Working Capital Deficit	$	(11,280,134	)	$	(12,426,546	)

Current assets for March 31, 2019 increased compared to December 31, 2018 primarily due to an increase in cash and inventory.

Current liabilities for March 31, 2019 decreased compared to December 31, 2018 primarily due to a decrease in Warrant liability. This was offset by an increase in accounts payable, customer deposits, accrued liabilities, and an increase in convertible notes payable.

Cash Flows

	Three Months Ended March 31,
	2019			2018
Net Cash Provided by (Used in) Operating Activities	$	(127,194	)	$	(81,438	)
Net Cash Provided by Financing Activities		200,000			-
Net Change	$	72,806		$	(81,438	)

Net Cash Provided by (Used in) Operating Activities

Our primary uses of cash from operating activities include payments to consultants for research and development, compensation and related costs, legal and professional fees and other general corporate expenditures.

Cash used in operating activities consist of net income adjusted for certain non-cash items, primarily equity-based compensation expense, the change in fair value of derivative liabilities due primarily to the mark to market of the Company’s derivatives embedded in the convertible notes, during the three months ended March 31, 2019, as well as the effect of changes in working capital and other activities, and the change in fair value of warrant liability which was affected by the cashless exercise.

Net Cash Provided by Financing Activities

For the three months ended March 31, 2019 and 2018, financing activities provided cash of $200,000 and $0.

Going Concern

At March 31, 2019, we had an accumulated deficit of $39,670,860. We expect to incur further losses in the development of our business, all of which casts substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern is dependent upon our ability to generate future profitable operations and/or to obtain the necessary financing to meet our obligations and repay our liabilities arising from normal business operations when they come due.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS.

The Company is not required to provide the information required under this Item 3.

Item 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of our disclosure controls and procedures, as such term is defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Quarterly Report on Form 10-Q, to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure, and that such information is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms. Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are not effective as of March 31, 2019, due to the fact that management has not fully remediated the material weakness described in our Current Report on Form 10-K filed with the Securities and Exchange Commission on April 25, 2019.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the three months ended March 31, 2019, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

In the ordinary course of business, we are subject to claims and litigation, including claims that we infringe third party patents, trademarks and other intellectual property rights. Although we believe it is unlikely that any current claims or actions will have a material adverse impact on our operating results or our financial position, given the uncertainty of litigation, we cannot be certain of this. Moreover, the defense of claims or actions against us, even if not meritorious, could result in the expenditure of significant financial and managerial resources.

Our involvement in any patent dispute, other intellectual property dispute or action to protect trade secrets and know-how could result in a material adverse effect on our business. Adverse determinations in current litigation or any other litigation in which we may become involved and regulatory non-compliance, including with respect to export regulations, could subject us to significant liabilities to third parties or government agencies, require us to grant licenses to or seek licenses from third parties and prevent us from manufacturing and selling our products. Any of these situations could have a material adverse effect on our business.

All Quality & Services, Inc. Matter

On October 18, 2018, ALL QUALITY & SERVICES, INC., a California corporation (“AQS”), filed a complaint (the “AQS Complaint”) in the Superior Court of California, County of Alameda against the Company alleging breach of contract relating to certain purchase orders and purchases related thereto. On February 14, 2019, the Company settled the matter with AQS by paying $25,000 cash to AQS and agreeing to pay a minimum of $15,000 each month until 2,000 units have been purchased from AQS which shall not be later than March 1, 2021.

Lawsuit Against Jerome Dewald and Skip Sanzeri

As previously disclosed, in July 2017, the Company and its CEO (collectively, the “Plaintiffs”) filed a lawsuit against Jerome Dewald and Skip Sanzeri. On or about July 9, 2018, the Company settled with Mr. Dewald and has dismissed the matter with prejudice as to Mr. Dewald. On or about July 25, 2018, the Company settled with Mr. Sanzeri, which settlement calls for settlement payments of $1,000 per month over the course of five months, after which the Company will dismiss the matter as to Mr. Sanzeri and fully dispose of the lawsuit. As of April 23, 2019, all five $1,000 payments have been made to the Company and the matter has not yet been dismissed.

Lawsuit Against Bright Light Marketing, Inc.

On March 10, 2017, the Company and Bright Light Marketing, Inc. (“BLM”) entered into a Settlement Agreement (the “BLM Settlement”). Pursuant to the BLM Settlement, BLM was to pay the Company a total of $217,500 over the twelve (12) months following March 13, 2017. BLM’s first payment of $100,000 was due within thirty (30) business days of the signing of the BLM Settlement. BLM was then to pay the Company $10,000 per month on the first day of the next eleven (11) months and the final payment of $7,500 was due on March 1, 2018.

As of January 22, 2018, BLM had not made any payments to the Company pursuant to the BLM Settlement. On that date, the Company filed a complaint in Superior Court of California against BLM to enforce the BLM Settlement amount of $217,500 and to collect interest at the default rate of $47.67 per day. In addition, the Company is seeking court costs and attorney’s fees. BLM answered the complaint on March 12, 2018. The initial case management conference was in May 2018. Defendant did not make an appearance and the court set a continued case management conference for July 24, 2018, where the court struck the answer for BLM. The court set trial for May 13, 2019 at 8:30 a.m. and required MyDx’s counsel to reach out to defendant for settlement purposes.

Item 1A. RISK FACTORS

We believe there are no changes that constitute material changes from the risk factors previously disclosed in our Annual Report on Form 10-K, filed with the SEC on April 25, 2019.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no unregistered sales of the Company’s equity securities during the quarter ended March 31, 2019, that were not otherwise disclosed in a Current Report on Form 8-K. The Company has not repurchased shares of its Common Stock

Item 3. DEFAULTS UPON SENIOR SECURITIES

There has been no default in the payment of principal, interest, sinking or purchase fund installment, or any other material default, with respect to any indebtedness of the Company.

Item 4. MINE SAFETY DISCLOSURES

None.

Item 5. OTHER INFORMATION

None.

Item 6. EXHIBITS

Exhibits:

31.1	Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2	Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	MYDX, INC.

Dated: June 7, 2019	By:	/s/ Matthew Bucciero
		Matthew Bucciero
		Principal Executive Officer and Chief Financial Officer (signed both as an Officer duly authorized to sign on behalf of the Registrant and Principal Financial Officer and Chief Accounting Officer)

EX-31.1 2 f10q0319ex31-1_mydxinc.htm CERTIFICATION

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Matthew Bucciero, certify that:

	1.	I have reviewed this quarterly report on Form 10-Q (hereinafter referred to as “this report”) of MyDx, Inc. (hereinafter referred to as “the registrant”);

	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

	4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

	b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to affect, the registrant’s internal control over financial reporting; and;

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions);

	a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: June 7, 2019	By:	/s/ Matthew Bucciero
		Matthew Bucciero
		Chief Executive Officer (Principal Executive Officer)

EX-31.2 3 f10q0319ex31-2_mydxinc.htm CERTIFICATION

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Matthew Bucciero, certify that:

	1.	I have reviewed this quarterly report on Form 10-Q (hereinafter referred to as “this report”) of MyDx, Inc. (hereinafter referred to as “the registrant”);

	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

	4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

	b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to affect, the registrant’s internal control over financial reporting; and;

	a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: June 7, 2019	By:	/s/ Matthew Bucciero
		Matthew Bucciero
		Chief Financial Officer (Principal Accounting Officer)

EX-32 4 f10q0319ex32_mydxinc.htm CERTIFICATION

EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of MyDx, Inc., a Nevada corporation (the “Company”), on Form 10-Q for the quarter ended September 30, 2018, as filed with the Securities and Exchange Commission (the “Report”), Matthew Bucciero, Chief Executive Officer and Chief Financial Officer, does hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. ss. 1350), that to her knowledge:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: June 7, 2019

/s/ Matthew Bucciero

EX-101.INS 5 mydx-20190331.xml XBRL INSTANCE FILE 0001582341 2019-01-01 2019-03-31 0001582341 2017-12-31 0001582341 2018-12-31 0001582341 us-gaap:SeriesAPreferredStockMember 2017-12-31 0001582341 us-gaap:SeriesAPreferredStockMember 2018-12-31 0001582341 us-gaap:SeriesBPreferredStockMember 2018-07-31 0001582341 us-gaap:SeriesBPreferredStockMember 2018-07-30 0001582341 us-gaap:PreferredStockMember 2016-09-30 0001582341 2018-01-01 2018-03-31 0001582341 us-gaap:SoftwareDevelopmentMember 2019-01-01 2019-03-31 0001582341 us-gaap:EquipmentMember srt:MinimumMember 2019-01-01 2019-03-31 0001582341 us-gaap:EquipmentMember srt:MaximumMember 2019-01-01 2019-03-31 0001582341 us-gaap:ComputerEquipmentMember srt:MinimumMember 2019-01-01 2019-03-31 0001582341 us-gaap:ComputerEquipmentMember srt:MaximumMember 2019-01-01 2019-03-31 0001582341 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2019-01-01 2019-03-31 0001582341 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2019-01-01 2019-03-31 0001582341 us-gaap:LeaseholdImprovementsMember 2019-01-01 2019-03-31 0001582341 us-gaap:WarrantMember 2018-01-01 2018-03-31 0001582341 mydx:ConvertibleAccountsPayableMember 2018-01-01 2018-03-31 0001582341 us-gaap:SeriesBPreferredStockMember 2018-01-01 2018-03-31 0001582341 us-gaap:ConvertibleNotesPayableMember 2019-01-01 2019-03-31 0001582341 us-gaap:SeriesAPreferredStockMember 2019-01-01 2019-03-31 0001582341 mydx:OptionsMember 2019-01-01 2019-03-31 0001582341 us-gaap:WarrantMember 2019-01-01 2019-03-31 0001582341 mydx:ConvertibleAccountsPayableMember 2019-01-01 2019-03-31 0001582341 us-gaap:SeriesBPreferredStockMember 2019-01-01 2019-03-31 0001582341 us-gaap:ConvertibleNotesPayableMember 2018-01-01 2018-03-31 0001582341 us-gaap:SeriesAPreferredStockMember 2018-01-01 2018-03-31 0001582341 mydx:OptionsMember 2018-01-01 2018-03-31 0001582341 us-gaap:SellingAndMarketingExpenseMember 2018-01-01 2018-03-31 0001582341 us-gaap:GeneralAndAdministrativeExpenseMember 2018-01-01 2018-03-31 0001582341 us-gaap:SellingAndMarketingExpenseMember 2019-01-01 2019-03-31 0001582341 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-03-31 0001582341 us-gaap:ConvertibleNotesPayableMember 2018-12-31 0001582341 mydx:ConvertibleNotesPayableOneMember 2018-12-31 0001582341 mydx:ConvertibleNotesPayableTwoMember 2018-12-31 0001582341 mydx:ConvertibleNotesPayableThreeMember 2018-12-31 0001582341 mydx:ConvertibleNotesPayableFourMember 2018-12-31 0001582341 mydx:ConvertibleNotesPayableFiveMember 2018-12-31 0001582341 mydx:LendersMember 2018-07-23 0001582341 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember 2018-12-31 0001582341 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember 2018-12-31 0001582341 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2018-12-31 0001582341 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeMember 2018-12-31 0001582341 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember 2019-01-01 2019-03-31 0001582341 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember 2019-01-01 2019-03-31 0001582341 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2019-01-01 2019-03-31 0001582341 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeMember 2019-01-01 2019-03-31 0001582341 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001582341 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001582341 mydx:LendersMember 2018-12-31 0001582341 mydx:FairValueOfDerivativeLiabilityAndWarrantLiabilityMember srt:MaximumMember 2019-01-01 2019-03-31 0001582341 mydx:FairValueOfDerivativeLiabilityAndWarrantLiabilityMember srt:MinimumMember 2019-01-01 2019-03-31 0001582341 mydx:NotePurchaseAgreementMember 2018-12-31 0001582341 mydx:NotePurchaseAgreementMember 2019-01-01 2019-03-31 0001582341 mydx:LendersMember 2018-07-03 2018-07-23 0001582341 us-gaap:SeriesBPreferredStockMember 2018-07-05 2018-07-31 0001582341 us-gaap:SeriesBPreferredStockMember 2018-07-01 2018-07-30 0001582341 mydx:GenevaSecuritiesPurchaseAgreementMember 2018-09-26 2018-10-01 0001582341 mydx:GSCPurchaseAgreementMember 2018-12-01 2018-12-19 0001582341 mydx:GenevaSecuritiesPurchaseAgreementMember 2018-10-01 0001582341 mydx:GsCapitalSecuritiesPurchaseAgreementMember 2018-10-04 0001582341 mydx:GsCapitalSecuritiesPurchaseAgreementMember 2018-10-11 0001582341 mydx:EaglePurchaseAgreementMember 2018-10-11 0001582341 mydx:GenevaSecuritiesPurchaseAgreementMember 2018-10-02 0001582341 us-gaap:CommonStockMember 2016-09-30 0001582341 us-gaap:CommonStockMember 2017-12-31 0001582341 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001582341 us-gaap:RetainedEarningsMember 2017-12-31 0001582341 us-gaap:CommonStockMember 2018-12-31 0001582341 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001582341 us-gaap:RetainedEarningsMember 2018-12-31 0001582341 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001582341 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001582341 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001582341 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001582341 mydx:ProductRevenueMember country:US 2019-01-01 2019-03-31 0001582341 mydx:ProductRevenueMember mydx:InternationalMember 2019-01-01 2019-03-31 0001582341 mydx:ProductRevenueMember 2019-01-01 2019-03-31 0001582341 country:US 2019-01-01 2019-03-31 0001582341 mydx:InternationalMember 2019-01-01 2019-03-31 0001582341 mydx:ProductRevenueMember country:US 2018-01-01 2018-03-31 0001582341 mydx:ProductRevenueMember mydx:InternationalMember 2018-01-01 2018-03-31 0001582341 mydx:ProductRevenueMember 2018-01-01 2018-03-31 0001582341 country:US 2018-01-01 2018-03-31 0001582341 mydx:InternationalMember 2018-01-01 2018-03-31 0001582341 country:US mydx:ProductServiceRevenueMember 2019-01-01 2019-03-31 0001582341 country:US mydx:ProductServiceRevenueMember 2018-01-01 2018-03-31 0001582341 mydx:ProductServiceRevenueMember mydx:InternationalMember 2019-01-01 2019-03-31 0001582341 mydx:ProductServiceRevenueMember mydx:InternationalMember 2018-01-01 2018-03-31 0001582341 mydx:ProductServiceRevenueMember 2019-01-01 2019-03-31 0001582341 mydx:ProductServiceRevenueMember 2018-01-01 2018-03-31 0001582341 mydx:LicensingRevenueMember 2019-01-01 2019-03-31 0001582341 mydx:LicensingRevenueMember 2018-01-01 2018-03-31 0001582341 mydx:LicensingRevenueMember country:US 2019-01-01 2019-03-31 0001582341 mydx:LicensingRevenueMember country:US 2018-01-01 2018-03-31 0001582341 mydx:LicensingRevenueMember mydx:InternationalMember 2019-01-01 2019-03-31 0001582341 mydx:LicensingRevenueMember mydx:InternationalMember 2018-01-01 2018-03-31 0001582341 2019-03-31 0001582341 us-gaap:SeriesAPreferredStockMember 2019-03-31 0001582341 2018-03-31 0001582341 us-gaap:CommonStockMember 2018-03-31 0001582341 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001582341 us-gaap:RetainedEarningsMember 2018-03-31 0001582341 us-gaap:SeriesAPreferredStockMember 2018-03-31 0001582341 us-gaap:CommonStockMember 2019-03-31 0001582341 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001582341 us-gaap:RetainedEarningsMember 2019-03-31 0001582341 us-gaap:RedeemablePreferredStockMember 2018-12-31 0001582341 us-gaap:RedeemablePreferredStockMember 2019-03-31 0001582341 mydx:ConvertibleNotesPayableSixMember 2018-12-31 0001582341 us-gaap:ConvertibleNotesPayableMember 2019-03-31 0001582341 mydx:ConvertibleNotesPayableOneMember 2019-03-31 0001582341 mydx:ConvertibleNotesPayableTwoMember 2019-03-31 0001582341 mydx:ConvertibleNotesPayableThreeMember 2019-03-31 0001582341 mydx:ConvertibleNotesPayableFourMember 2019-03-31 0001582341 mydx:ConvertibleNotesPayableFiveMember 2019-03-31 0001582341 mydx:ConvertibleNotesPayableSixMember 2019-03-31 0001582341 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember 2019-03-31 0001582341 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember 2019-03-31 0001582341 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2019-03-31 0001582341 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeMember 2019-01-01 2019-03-31 0001582341 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeMember 2019-01-01 2019-03-31 0001582341 us-gaap:CommonStockMember 2019-01-15 0001582341 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeMember 2018-12-31 0001582341 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeMember 2019-03-31 0001582341 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeMember 2018-12-31 0001582341 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeMember 2019-03-31 0001582341 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeMember 2019-03-31 0001582341 mydx:LGCapitalFundingLLCMember us-gaap:SubsequentEventMember 2019-04-15 2019-05-02 0001582341 mydx:LGCapitalFundingLLCMember us-gaap:SubsequentEventMember 2019-05-02 0001582341 us-gaap:SubsequentEventMember mydx:OdysseyCapitalFundingLLCMember 2019-04-15 2019-05-07 0001582341 us-gaap:SubsequentEventMember mydx:OdysseyCapitalFundingLLCMember 2019-05-07 0001582341 us-gaap:SeriesBPreferredStockMember 2018-01-01 2018-12-31 0001582341 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001582341 mydx:LendersMember 2018-01-01 2018-12-31 0001582341 mydx:NotePurchaseAgreementMember 2018-01-01 2018-12-31 0001582341 mydx:HasperIncMember mydx:AmendmentMember 2017-12-31 0001582341 mydx:HasperIncMember mydx:AmendmentMember 2016-12-31 0001582341 mydx:HasperIncMember mydx:AmendmentMember 2017-01-01 2017-12-31 0001582341 mydx:HasperIncMember mydx:AmendmentMember 2017-12-27 0001582341 mydx:HasperIncMember mydx:AmendmentMember 2017-12-01 2017-12-27 0001582341 mydx:SeriesAPreferredMember 2019-01-01 2019-03-31 0001582341 mydx:SeriesAPreferredMember 2018-01-01 2018-03-31 0001582341 2019-06-07 0001582341 mydx:GsCapitalSecuritiesPurchaseAgreementMember 2018-09-27 2018-10-05 0001582341 mydx:EagleAndGSCSecuritiesPurchaseAgreementsMember 2018-09-17 2018-10-11 0001582341 mydx:EaglePurchaseAgreementMember 2018-09-26 2018-10-11 0001582341 mydx:GsCapitalSecuritiesPurchaseAgreementMember 2018-10-03 2018-10-11 0001582341 mydx:GSCapitalPartnersMember 2019-03-01 2019-03-07 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure MyDx, Inc. 0001582341 false --12-31 10-Q MYDX 2019-03-31 2019 Q1 Non-accelerated Filer

0.001

1.00

0.001

P3Y

P5Y

P3Y

P7Y

P5Y

P7Y

Shorter of life of asset or lease

27851

37253

54290

19070

1222186

1253732

25000

60000

102000

181500

63945

236250

0.00 0.00 0.00 0.0244 0.0240 1.14 1.03 true true

2019-07-23

2020-05-02

119028

102698

175504

37590

10000000000

-14239961

1859397

19818536

-31632972

3905201

21820069

-39965231

-13099708

1894397

19961007

-30753067

4070747

22500405

-39670860

879905

283670

879905

294370

false

4043156414

1878730874

346554654

2967000000

738212072

1615879300

330000000

1070000000

128586957

Basis of Presentation - Unaudited Interim Financial Information   The accompanying unaudited interim condensed consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the "SEC") with respect to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company's annual report on Form 10-K for the year ended December 31, 2018.

Use of Estimates   The preparation of the consolidated finance statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Such management estimates include allowance for doubtful accounts, estimates of product returns, warranty expense, inventory valuation, valuation allowances of deferred taxes, stock-based compensation expenses and fair value of warrants and derivatives. The Company bases its estimates on historical experience and on assumptions that it believes are reasonable. The Company assesses these estimates on a regular basis; however, actual results could materially differ from those estimates.

Concentration of Risk Related to Third-party Suppliers   We depend on a limited number of third-party suppliers for the materials and components required to manufacture our products. A delay or interruption by our suppliers may harm our business, results of operations, and financial condition, and could also adversely affect our future profit margins. In addition, the lead time needed to establish a relationship with a new supplier can be lengthy, and we may experience delays in meeting demand in the event we must change or add new suppliers. Our dependence on our suppliers exposes us to numerous risks, including but not limited to the following: our suppliers may cease or reduce production or deliveries, raise prices, or renegotiate terms; we may be unable to locate a suitable replacement supplier on acceptable terms or on a timely basis, or at all; and delays caused by supply issues may harm our reputation, frustrate our customers, and cause them to turn to our competitors for future needs.

Fair Value of Financial Instruments   The Company recognizes and discloses the fair value of its assets and liabilities using a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). Each level of input has different levels of subjectivity and difficulty involved in determining fair value.   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 48px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="width: 8%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Level 1</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurable date.</td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Level 2</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Inputs, other than quoted prices included in Level 1, that are observable for the asset or liability through corroboration with market data at the measurement date.</td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Level 3</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Unobservable inputs that reflect management's best estimate of what participants would use in pricing the asset or liability at the measurement date.</td></tr> </table>   The carrying amounts of the Company's financial assets and liabilities, including cash, accounts receivable, accounts payable, and accrued liabilities approximate fair value because of the short maturity of these instruments. The carrying value of the Company's loan payable and convertible notes payable approximates fair value based upon borrowing rates currently available to the Company for loans with similar terms.

Business Segments   ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company's condensed consolidated financial statements as substantially all of the Company's operations are conducted in one industry segment.

Cash   The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. As of March 31, 2019 and December 31, 2018, the Company held no cash equivalents.   The Company's policy is to place its cash with high credit quality financial instruments and institutions and limit the amounts invested with any one financial institution or in any type of instrument. Deposits held with banks may exceed the amount of insurance provided on such deposits. The Company has not experienced any losses on its deposits of cash.

Inventory   Inventory is stated at the lower of cost or market value. Inventory is determined to be salable based on demand forecast within a specific time horizon, generally eighteen months or less. Inventory in excess of salable amounts and inventory which is considered obsolete based upon changes in existing technology is written off. At the point of recognition, a new lower cost basis for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in that new cost basis.

Property and Equipment   Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the useful life as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="width: 51%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Internal-use software</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="width: 48%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">3 years</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Equipment</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">3 to 5 years</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Computer equipment</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">3 to 7 years</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Furniture and fixtures</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">5 to 7 years</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Leasehold improvements</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Shorter of life of asset or lease</td></tr></table>

Accounting for Website Development Costs   The Company capitalizes certain external and internal costs, including internal payroll costs, incurred in connection with the development of its website. These costs are capitalized beginning when the Company has entered the application development stage and cease when the project is substantially complete and is ready for its intended use. The website development costs are amortized using the straight-line method over the estimated useful life of three years.

Impairment of Long-Lived Assets   Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of would be separately presented in the balance sheets and reported at the lower of the carrying amount or fair value less costs to sell, and no longer depreciated. The assets and liabilities of a disposed group classified as held for sale would be presented separately in the appropriate asset and liability sections of the balance sheets.

Debt Discount and Debt Issuance Costs   Debt discounts and debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense based on the related debt agreements using the straight-line method. Unamortized discounts are netted against long-term debt.

Derivative Liability   In accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Paragraph 815-15-25-1 the conversion feature and certain other features are considered embedded derivative instruments, such as a conversion reset provision, a penalty provision and redemption option, which are to be recorded at their fair value as its fair value can be separated from the convertible note and its conversion is independent of the underlying note value. The Company records the resulting discount on debt related to the conversion features at initial transaction and amortizes the discount using the effective interest rate method over the life of the debt instruments. The conversion liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations.   In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.    The Company follows ASC Section 815-40-15 ("Section 815-40-15") to determine whether an instrument (or an embedded feature) is indexed to the Company's own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument's contingent exercise and settlement provisions. The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.   The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.    The Company utilizes the binomial option pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The binomial option pricing model includes subjective input assumptions that can materially affect the fair value estimates. The expected volatility is estimated based on the most recent historical period of time equal to the remaining contractual term of the instrument granted.

Product Returns   For any product in its original, undamaged and unmarked condition, with its included accessories and packaging along with the original receipt (or gift receipt) within 30 days of the date the customer receives the product, the Company will exchange it or offer a refund based upon the original payment method. Customer Deposits   The Company accounts for funds received from crowdfunding campaigns and pre-sales as a liability on the consolidated balance sheets as the investments made entitle the investor to apply these funds towards future shipments once the product has been developed and available for commercial use.

Research and Development Costs   Research and development costs are charged to expense as incurred. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased materials and services provided by independent contractors, software developed by other companies and incorporated into or used in the development of our final products. Research and development expenses for the three months ended March 31, 2019 and 2018 were $13,935 and $233,090, respectively.

Advertising Costs   Advertising costs are charged to sales and marketing expenses and general and administrative expenses as incurred. Advertising expenses, which are recorded in sales and marketing and general and administrative expenses, totaled $54,290 and $52,253 for the three months ended March 31, 2019 and 2018, respectively.

Collaborative Arrangements   The Company and its collaborative partners are active participants in the collaborative arrangements and both parties are exposed to significant risks and rewards depending on the commercial success of the activity. The Company records all expenses related to collaborative arrangements as research and development expense in the consolidated statements of operations as incurred.

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="width: 51%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Internal-use software</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="width: 48%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">3 years</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Equipment</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">3 to 5 years</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Computer equipment</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">3 to 7 years</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Furniture and fixtures</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">5 to 7 years</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Leasehold improvements</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Shorter of life of asset or lease</td></tr> </table>

1539

76429

494

757

1251

782

757

39666

27178

66844

47264

29165

288

3468

1987

288

5455

4130

38272

45355

107000

3905200946

4070747508

165546562

-815970

-135244

6267426 4851348 -845883 0.07

189700

1897000000

26086956

99891304

10000000

The Series A Preferred Stock can convert into common stock at a 1:1 ratio. Each one (1) share of the Series A Preferred shall have voting rights equal to (x) 0.019607 multiplied by the total issued and outstanding shares of Common Stock eligible to vote at the time of the respective vote (the ?Numerator?), divided by (y) 0.49, minus (z) the Numerator. For purposes of illustration only, if the total issued and outstanding shares of Common Stock eligible to vote at the time of the respective vote is 5,000,000, the voting rights of one share of the Series A Preferred Stock shall be equal to 102,036 (0.019607 x 5,000,000) / 0.49) ? (0.019607 x 5,000,000) = 102,036). On December 23, 2016 the 51 shares were issued to Mr. Yazbeck, the Company?s sole officer and the sole member of the Board. Mr. Yazbeck, via his ownership of the 51 shares of the Series A Preferred, has control of the majority of the Company?s voting stock.

51 51

The Company also agreed to the assignment or issuance of three warrants giving the holder the right to purchase seven and one half percent (7.5%) of the Company?s shares of Common Stock issued and outstanding at the time of exercise and having an exercise price of $0.001 per share. This form of warrant is referred to herein as the ?7.5% Warrant.? The Company agreed to the assignment of one previously issued 7.5% Warrant to an entity related to BCI Advisors. This 7.5% Warrant will expire on July 31, 2020. In addition, the Company also agreed to the assignment of another previously issued 7.5% Warrant to an entity related to BCI Advisors and agreed to extend the expiration date from March 1, 2019 to July 31, 2020. Finally, the Company agreed to issue a new 7.5% Warrant which will expire on July 31, 2020. The Company currently does not have enough authorized shares to issue the Series B Preferred shares and therefore, have recorded them as a liability at their fair value of $1,262,976.

The Company also agreed to issue a 7.5% Warrant with an expiration date of July 31, 2020. The Company currently does not have enough authorized shares to issue the Series B shares and therefore, have recorded them as a liability at their fair value of $1,587,425.

74800

75000

126000

0.12

0.10

0.08

0.24

Accounts Receivable and Allowance for Doubtful Accounts   Accounts receivable are recorded at the invoiced amount and are not interest bearing. The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. The Company makes ongoing assumptions relating to the collectability of its accounts receivable in its calculation of the allowance for doubtful accounts. In determining the amount of the allowance, the Company makes judgments about the creditworthiness of customers based on ongoing credit evaluations and assesses current economic trends affecting its customers that might impact the level of credit losses in the future and result in different rates of bad debts than previously seen. The Company also considers its historical level of credit losses. As of March 31, 2019 and December 31, 2018, there was an allowance for doubtful accounts of $27,851 and $27,851 respectively.   During the three months ended March 31, 2019 and 2018 the Company recorded a bad debt expense of $0 and $0, respectively.

Revenue Recognition   The Company adopted ASC 606 effective January 1, 2018 using the modified retrospective method which would require a cumulative effect adjustment for initially applying the new revenue standard as an adjustment to the opening balance of retained earnings and the comparative information would not require to be restated and continue to be reported under the accounting standards in effect for those periods.   Based on the Company's analysis the Company did not identify a cumulative effect adjustment for initially applying the new revenue standards. The Company principally generates revenue through providing product, services and licensing revenue   The adoption of ASC 606 represents a change in accounting principle that will more closely align revenue recognition with the delivery of the Company's services and will provide financial statement readers with enhanced disclosures. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. To achieve this core principle, the Company applies the following five steps:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 34px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">1)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Identify the contract with a customer</td></tr> </table>   A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party's rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for services that are transferred is probable based on the customer's intent and ability to pay the promised consideration. The Company applies judgment in determining the customer's ability and intention to pay, which is based on a variety of factors including the customer's historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.    <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 34px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">2)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Identify the performance obligations in the contract</td></tr> </table>   Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services, the Company must apply judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met the promised services are accounted for as a combined performance obligation.   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 34px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">3)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Determine the transaction price</td></tr> </table>   The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring services to the customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Company's judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company's contracts as of December 31, 2018 contained a significant financing component. Determining the transaction price requires significant judgment, which is discussed by revenue category in further detail below.   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 34px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">4)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Allocate the transaction price to performance obligations in the contract</td></tr> </table>   If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series of distinct services that are substantially the same qualifies as a single performance obligation in a contract with variable consideration, the Company must determine if the variable consideration is attributable to the entire contract or to a specific part of the contract. For example, a bonus or penalty may be associated with one or more, but not all, distinct services promised in a series of distinct services that forms part of a single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that forms part of a single performance obligation. The Company determines standalone selling price based on the price at which the performance obligation is sold separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 34px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">5)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Recognize revenue when or as the Company satisfies a performance obligation</td></tr> </table>   The Company satisfies performance obligations either over time or at a point in time. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised service to a customer.    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months ended March 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months ended March 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">United States</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">International</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">United States</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">International</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Product Revenue</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">494</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">757</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,251</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">39,666</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">27,178</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">66,844</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product Service Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">288</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">288</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,987</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,455</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Licensing Revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,130</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,130</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">782</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">757</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,539</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">47,264</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">29,165</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">76,429</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>    Product revenue   Revenue from multiple-element arrangements is allocated among separate elements based on their estimated sales prices, provided the elements have value on a stand-alone basis.   Licensing revenue   Some of the Company's revenues are generated from software-as-a-service ("SaaS") subscription offerings and related product support and maintenance. SaaS revenues stem mainly from annual subscriptions and are recorded evenly over the term of the subscription. Any customer payments received in advance are deferred until they are earned. Consulting and training revenues are recognized as work is performed.

Stock-Based Compensation   The Company accounts for stock-based compensation in accordance with ASC Topic 718, "Compensation – Stock Compensation" ("ASC 718") which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value-based method of accounting for an employee stock option or similar equity instrument. Accordingly, stock-based compensation is recognized in the consolidated statements of operations as an operating expense over the requisite service period. The Company uses the Black-Scholes option pricing model adjusted for the estimated forfeiture rate for the respective grant to determine the estimated fair value of stock-based compensation arrangements on the date of grant and expenses this value ratably over the requisite service period of the stock option. The Black-Scholes option pricing model requires the input of highly subjective assumptions. Because the Company's stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's opinion, the existing models may not provide a reliable single measure of the fair value of the Company's stock options. In addition, management will continue to assess the assumptions and methodologies used to calculate estimated fair value of stock-based compensation. Circumstances may change and additional data may become available over time, which could result in changes to these assumptions and methodologies for future grants, and which could materially impact the Company's fair value determination.

Recent Accounting Guidance Adopted   In February 2016, the FASB issued ASU 2016-02 "Leases" (Topic 842) which amended guidance for lease arrangements to increase transparency and comparability by providing additional information to users of financial statements regarding an entity's leasing activities. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as ASC 842. The revised guidance seeks to achieve this objective by requiring reporting entities to recognize lease assets and lease liabilities on the balance sheet for substantially all lease arrangements.   On January 1, 2019, the Company adopted ASC 842 using the modified retrospective approach. Results for the three months ended March 31, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the legacy accounting guidance under ASC Topic 840, Leases.   As part of the adoption we elected the practical expedients permitted under the transition guidance within the new standard, which among other things, allowed us to:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 24px; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="width: 24px; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">1.</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Continue applying our current policy for accounting for land easements that existed as of, or expired before, January 1, 2019.</td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">2.</td> <td style="padding: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0">Not separate non-lease components from lease components and instead to account for each separate lease component and the non-lease components associated with that lease component as a single lease component.</td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">3.</td> <td style="padding: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0">Not to apply the recognition requirements in ASC 842 to short-term leases.</td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">4.</td> <td style="padding: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0">Not record a right of use asset or right of use liability for leases with an asset or liability balance that would be considered immaterial.</td></tr></table>

0.08

0.12

100000

127890

1890

0.0499

0.08

0.12

The LG Note is convertible into common stock at any time after the six-month anniversary of the LG Note, at LG Capital’s option, at a price equal to 65% of the average of the two lowest closing trading prices of the common stock during the fifteen-day period prior to conversion. The LG Note may not be prepaid more than 180 days prior to its maturity date. In the event the Company prepays the LG Note in full during the 180 days prior to its maturity date, the Company must pay off all principal, interest and any other amounts owing multiplied by a premium ranging from 5% to 30%.

The Odyssey Note is convertible into common stock at any time after the six-month anniversary of the Odyssey Note, at Odyssey’s option, at a price equal to 60% of the lowest closing trading price of the common stock during the twenty day period prior to conversion. The Odyssey Note may not be prepaid more than 180 days prior to its maturity date. In the event the Company prepays the Note in full during the 180 days prior to its maturity date, the Company must pay off all principal, interest and any other amounts owing multiplied by a premium ranging from 25% to 45%.

20241

8751

-135244 -1365055

-636603

-476399

9067645

261835149

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 48px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">7.</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Derivative Liabilities</td></tr> </table>   The Company has identified derivative instruments arising from embedded conversion features in the Company’s convertible notes payable and accounts payable at March 31, 2019.   The following summarizes the Binomial-lattice model assumptions used to estimate the fair value of the derivative liability and warrant liability at the date of issuance and for the convertible notes converted during the three months ended March 31, 2019.   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Low</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">High</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Annual dividend rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected life in years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">.32</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.40</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.44</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">103</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">114</td><td style="text-align: left">%</td></tr> </table>   Risk-free interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar term on the date of the grant.   Dividend yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future.   Volatility: The volatility was estimated using the historical volatilities of the Company’s common stock.   Remaining term: The Company’s remaining term is based on the remaining contractual maturity of the convertible notes payable and accounts payable.   The following are the changes in the derivative liabilities during the three months ended March 31, 2019.   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended March 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Derivative Liability as of January 1, 2019</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">     </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">    </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,222,186</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Initial derivative expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">166,790</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Gain on changes in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(135,244</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt">Derivative liabilities as of March 31, 2019</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,253,732</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>   The following are the changes in the warrant liabilities during the three months ended March 31, 2019.   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended March 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Balance, January 1, 2019</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">    -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">   -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,267,426</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Change due to exercise of warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(845,883</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gain on changes in fair value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(815,970</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accretion of warrant expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">245,775</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Warrant liabilities as March 31, 2019</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,851,348</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr></table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Low</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">High</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Annual dividend rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected life in years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">.32</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.40</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.44</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">103</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">114</td><td style="text-align: left">%</td></tr></table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended March 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Derivative Liability as of January 1, 2019</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">     </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">    </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,222,186</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Initial derivative expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">166,790</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Gain on changes in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(135,244</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt">Derivative liabilities as of March 31, 2019</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,253,732</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr></table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended March 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Balance, January 1, 2019</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">    -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">   -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,267,426</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Change due to exercise of warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(845,883</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gain on changes in fair value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(815,970</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accretion of warrant expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">245,775</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Warrant liabilities as March 31, 2019</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,851,348</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr></table>

P1Y P0Y3M26D 166790 245775

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 48px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">8.</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Stockholders’ Deficit</td></tr> </table>   Preferred Stock   On September 30, 2016, the Company filed a Certificate of Amendment to Articles of Incorporation with the Secretary of State of the State of Nevada to authorize for issuance ten million (10,000,000) shares of blank check preferred stock, par value $0.001 (“Blank Check Preferred Stock”) as included on Form 8-K filed with the SEC on October 4, 2016.   Series A Preferred Stock   As of March 31, 2019, and March 31, 2018, the Company has designated 51 shares of Series A Preferred Stock par value $0.001 and 51 shares are issued and outstanding. The Series A Preferred Stock can convert into common stock at a 1:1 ratio. Each one (1) share of the Series A Preferred shall have voting rights equal to (x) 0.019607 multiplied by the total issued and outstanding shares of Common Stock eligible to vote at the time of the respective vote (the “Numerator”), divided by (y) 0.49, minus (z) the Numerator. For purposes of illustration only, if the total issued and outstanding shares of Common Stock eligible to vote at the time of the respective vote is 5,000,000, the voting rights of one share of the Series A Preferred Stock shall be equal to 102,036 (0.019607 x 5,000,000) / 0.49) – (0.019607 x 5,000,000) = 102,036). On December 23, 2016 the 51 shares were issued to Mr. Yazbeck, the Company’s sole officer and the sole member of the Board. Mr. Yazbeck, via his ownership of the 51 shares of the Series A Preferred, has control of the majority of the Company’s voting stock.   Series B Preferred Stock   The Series B Preferred is convertible into shares of Common Stock at a conversion price of $0.0001. Holders of the Series B Preferred are entitled to receive dividends annually equal to $0.10 for each share of Series B Preferred held. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series B Preferred then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders, before any payment shall be made to the holders of Common Stock. Until such time as there are fewer than 20,000 shares of Series B Preferred outstanding, the Company needs to obtain the majority votes of the holders of Series B Preferred with regard to certain actions. Holders of Series B Preferred shares are entitled to one vote for each share held, are entitled to elect up to two members to the Board, and, absent such election, are provided certain voting and veto rights with regard to any vote by the Board.   On July 31, 2018, the Company agreed to eventually issue 38,272 shares of Series B Preferred at a value of $1.00 per Series B Preferred share to settle outstanding vendor liability. The shares of Series B Preferred will be issued upon an increase in the authorized shares of Series B Preferred. The Company also agreed to the assignment or issuance of three warrants giving the holder the right to purchase seven and one half percent (7.5%) of the Company’s shares of Common Stock issued and outstanding at the time of exercise and having an exercise price of $0.001 per share. This form of warrant is referred to herein as the “7.5% Warrant.” The Company agreed to the assignment of one previously issued 7.5% Warrant to an entity related to BCI Advisors. This 7.5% Warrant will expire on July 31, 2020. In addition, the Company also agreed to the assignment of another previously issued 7.5% Warrant to an entity related to BCI Advisors and agreed to extend the expiration date from March 1, 2019 to July 31, 2020. Finally, the Company agreed to issue a new 7.5% Warrant which will expire on July 31, 2020. The Company currently does not have enough authorized shares to issue the Series B Preferred shares and therefore, have recorded them as a liability at their fair value of $1,262,976.   On July 30, 2018, the Company agreed to eventually issue 45,355 shares of the Company’s Series B Preferred at a value of $1.00 per Series B Preferred share to settle outstanding vendor liability. The Company also agreed to issue a 7.5% Warrant with an expiration date of July 31, 2020. The Company currently does not have enough authorized shares to issue the Series B shares and therefore, have recorded them as a liability at their fair value of $1,587,425.   During the year ended December 31, 2018 investors converted 189,700 Series B Preferred stock in to 1,897,000,000 shares of common stock.   Common Stock   On September 30, 2016, the Company amended articles of incorporation to increase the number of authorized commons shares to 10,000,000,000 as included on Form 8-K filed with the SEC on October 4, 2016.   On January 15, 2019, the Company issued 165,546,562 shares of common stock for a cashless exercise on warrants.

1262976 1587425

7797250837

5320872536

-0.00

294370

879905

294370

879905

804861

1360804

4500 -154002 815970 135244 1519057

146353

8751

-510491

-480899

495147

530990

426922

245647

54290

52253

13935

233090

-15344

50091

16883

26338

16883

26338

4130 288 5455 1251 66844

10700

1859397541

3905200946

1894397541

4070747508

150000

30000

120000

30000000

25500 5000 20500 5000000

1971

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 48px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">5.</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Inventory</td></tr> </table>   Inventory as of March 31, 2019 and December 31, 2018 is as follows:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Finished goods</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,511</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,781</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Raw materials</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">150,445</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">104,250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">157,956</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">114,031</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr></table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 48px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">6.</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Debt</td></tr> </table>   Convertible Notes   The following table shows the outstanding balance as of March 31, 2019 and December 31, 2018 respectively.   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Convertible Note - February 6, 2017</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">265,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">265,750</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Convertible Note - July 23, 2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Convertible Note – October 1, 2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74,800</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Convertible Note – October 4, 2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Convertible Note – October 11, 2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">283,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">283,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Convertible Note – December 19, 2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">82,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">82,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Convertible Note – March 7, 2019</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">210,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,014,550</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">804,550</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Debt Discount</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(419,051</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(368,373</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">595,499</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">436,177</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>     Amendment 2   On December 27, 2017 the Company, Hasfer, Inc. and Legacy, entered into an amendment to the note. The note was modified as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">●</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">A portion of the outstanding principal and interest was assigned to Legacy.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">●</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">The company received proceeds of $48,500.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">●</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Fees related to the amendment totaled $1,500. The fees were recorded as a loss on extinguishment of debt.</td></tr> </table>   All remaining terms of the Revolving note remained the same.   In accordance with ASC 470, since the present value of the cash flows under the new debt instrument was at least ten percent different from the present value of the remaining cash flows under the terms of the original debt instrument, the Company accounted for the amendment to SPA as a debt extinguishment. Accordingly, the Company recorded a loss on extinguishment of debt of $155,086.   During the year ended December 31, 2017 Hasfer converted $236,250 of the outstanding principal into 99,891,304 share of the company's common stock.   As of December 31, 2017 and 2016 the balance of this agreement was $295,750 and $0 respectively.   During the year ended December 31, 2018 Hasfer, Inc and Carte Blanche, LLC entered into a note purchase agreement. Hasfer assigned $60,000 to Carte Blanche, LLC. The Company received additional proceeds of $30,000.   During the year ended the lenders converted $60,000 of the outstanding principal into 26,086,956 shares of the Company's common stock.   On July 23, 2018 the Company issued convertible notes to third party lenders totaling $25,000. These notes accrue interest at a rate of 12% per annum and mature with interest and principal due July 23, 2019. The note and accrued interest are convertible at a conversion price equal to a 30% discount of the Company's common stock prior day close price.   Due to the fact that these convertible notes have an option to convert at a variable amount, they are subject to derivative liability treatment. The Company has applied ASC 815, due to the potential for settlement in a variable quantity of shares. The conversion feature has been measured at fair value using a Binomial Option Pricing model at the issuance date and the period end. The conversion feature of the convertible note gave rise to a derivative liability of $19,070 which was recorded as a debt discount. The debt discount is charged to other expense ratably over the term of the convertible note   On July 23, 2018 the Company issued convertible notes to third party lenders totaling $25,000. The note accrues interest at a rate of 12% per annum and mature with interest and principal due July 23, 2019. The note and accrued interest are convertible at a conversion price equal to a 30% discount of the Company's common stock prior day close price.   Due to the fact that these convertible notes have an option to convert at a variable amount, they are subject to derivative liability treatment. The Company has applied ASC 815, due to the potential for settlement in a variable quantity of shares. The conversion feature has been measured at fair value using a Binomial Option Pricing model at the issuance date and the period end. The conversion feature of the convertible note gave rise to a derivative liability of $19,070 which was recorded as a debt discount. The debt discount is charged to other expense ratably over the term of the convertible note.   Geneva Securities Purchase Agreement   Effective October 1, 2018, the Company entered into a securities purchase agreement (the "Geneva Purchase Agreement") with Geneva Roth Remark Holdings, Inc., ("Geneva"), pursuant to which Geneva purchased a 10% unsecured convertible promissory note (the "Geneva Note") from the Company in the aggregate principal amount of $74,800, such principal and the interest thereon convertible into shares of the Company's common stock at the option of Geneva.    The purchase price of $74,800 of the Geneva Note was paid in cash by Geneva on October 2, 2018. After payment of transaction-related expenses, net proceeds to the Company from the Geneva Note totaled $65,000.   The maturity date of the Geneva Note is October 1, 2019 (the "Geneva Maturity Date"). The Geneva Note shall bear interest at a rate of ten percent (10%) per annum (the "Geneva Interest Rate"), which interest shall be paid by the Company to Geneva in shares of common stock at any time Geneva sends a notice of conversion to the Company. Geneva is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the Geneva Note into shares of the Company's common stock, at any time after March 20, 2019, at a conversion price for each share of common stock equal to 71% multiplied by the average of the lowest three (3) trading prices (as defined in the Geneva Purchase Agreement) for the common stock during the fifteen (15) Trading Day period (as defined in the Geneva Purchase Agreement) ending on the latest complete trading day prior to the conversion date.   The Geneva Note may be prepaid until 170 days from the issuance date in accordance with its terms.    The Company shall reserve 270,905,432 of its authorized and unissued common stock (the "Geneva Reserved Amount"), free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of the Geneva Note.   GS Capital Securities Purchase Agreement   Effective October 4, 2018 the Company entered into a securities purchase agreement (the "GSC Purchase Agreement") with GS Capital Partners LLC, ("GSC", and together with Geneva, the "Investors"), pursuant to which GSC purchased a 8% unsecured convertible promissory note from the Company in the aggregate principal amount of $75,000 (the "GSC Note"), such principal and the interest thereon convertible into shares of the Company's common stock at the option of GSC.   The purchase price of $75,000 of the GSC Note was paid in cash by GSC on October 5, 2018. After payment of transaction-related expenses, net proceeds to the Company from the First GSC Note totaled $68,500.   The maturity date of the GSC Note is October 4, 2019 (the "the GSC Maturity Date"). The GSC Note shall bear interest at a rate of eight percent (8%) per annum (the "GSC Interest Rate"), which interest shall be paid by the Company to GSC in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company's common stock, at any time, at the conversion price specified in the for each share of common stock equal to 71% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note the Company recorded a $58,855 debt discount.   The GSC Note may be prepaid until 180 days from the issuance date in accordance with its terms.   The Company shall reserve 211,267,000 of its authorized and unissued common stock (the "GSC Reserved Amount"), free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of the GSC Note.   Eagle and GSC Securities Purchase Agreements   Effective October 11, 2018, the Company entered into a securities purchase agreement (the "Eagle Purchase Agreement") with Eagle Equities, LLC ("Eagle"), pursuant to which Eagle purchased an 8% unsecured convertible promissory note (the "Eagle Note") from the Company in the aggregate principal amount of $181,500, such principal and the interest thereon convertible into shares of the Company's common stock at the option of Eagle.   Effective October 11, 2018 the Company entered into a securities purchase agreement (the "GSC Purchase Agreement" and together with the Eagle Purchase Agreement, the "SPAs") with GSC (together with Eagle, the "Investors"), pursuant to which GSC purchased an 8% unsecured convertible promissory note (the "GSC Note" and together with the Eagle Note, the "Notes") from the Company in the aggregate principal amount of $102,000, such principal and the interest thereon convertible into shares of the Company's common stock at the option of GSC.   The purchase price of $181,500, and of $102,000, of the Eagle Note and the GSC Note, respectively, was paid in cash by the Investors on October 11, 2018. After payment of transaction-related expenses, net proceeds to the Company from the Eagle Note and the GSC Note totaled $157,000 and $90,000, respectively.   The maturity date of the Notes is October 11, 2019 (the "Maturity Date"). The Notes shall bear interest at a rate of eight percent (8%) per annum (the "Interest Rate"), which interest shall be paid by the Company to the Investors in shares of common stock at any time Eagle or GSC sends a notice of conversion to the Company (the "Notice of Conversion"). The Investors are entitled to, at their option, convert all or any amount of the principal face amount and any accrued but unpaid interest of their respective Notes into shares of the Company's common stock, at any time, at a conversion price for each share of common stock equal to 65% multiplied by the lowest closing bid price of the common stock as reported on the marketplace upon which the Company's shares are traded during the fifteen (15) trading day period ending on the day upon which a Notice of Conversion is received by the Company. In connection with this note, the Company recorded a $149,702 and $85,085 debt discounts.   The Notes may be prepaid until 180 days from the issuance date in accordance with its terms.   The Company shall reserve 532,000,000, and 299,000,000, of its authorized and unissued common stock free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of the Eagle Note (the "Eagle Reserved Amount"), and the GSC Note (the "GSC Reserved Amount" and together with the Eagle Reserved Amount, the "Total Reserved Amount"), respectively.    Effective December 19, 2018 the Company entered into a securities purchase agreement (the "GSC Purchase Agreement") with GS Capital Partners LLC, ("GSC", and together with Geneva, the "Investors"), pursuant to which GSC purchased a 8% unsecured convertible promissory note from the Company in the aggregate principal amount of $82,000 (the "GSC Note"), such principal and the interest thereon convertible into shares of the Company's common stock at the option of GSC.   The purchase price of $82,000 of the GSC Note was paid in cash by GSC on December 19, 2018. After payment of transaction-related expenses, net proceeds to the Company from the First GSC Note totaled $76,000.   The maturity date of the GSC Note is December 19, 2019 (the "the GSC Maturity Date"). The GSC Note shall bear interest at a rate of eight percent (8%) per annum (the "GSC Interest Rate"), which interest shall be paid by the Company to GSC in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company's common stock, at any time, at the conversion price specified in the for each share of common stock equal to 67% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note, the Company recorded a $76,000 debt discount.   The GSC Note may be prepaid until 180 days from the issuance date in accordance with its terms.   The Company shall reserve 211,267,000 of its authorized and unissued common stock (the "GSC Reserved Amount"), free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of the GSC Note.   GS Capital Agreement   Effective March 7, 2019 the Company entered into a securities purchase agreement with GS Capital Partners, pursuant to which GSC purchased a 8% unsecured convertible promissory note from the Company in aggregate principal amount of $210,000, such principal and interest thereon convertible into shares of the Company's common stock at the option of GSC.   The purchase price of $210,000 of the GS Capital note was paid in cash by GS Capital on March 11, 2019. After payment of transaction-related expenses, net proceeds to the Company from the note totaled $200,000.   The maturity date of the GS Capital note is March 7, 2020. The GS Capital Note shall bear interest at a rate of eight percent (8%) per annum which interest shall be paid by the Company to GS Capital in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company's common stock, at any time, at the conversion price specified in the for each share of common stock equal to 65% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note, the Company recorded a $167,296 debt discount.

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Finished goods</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,511</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,781</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Raw materials</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">150,445</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">104,250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">157,956</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">114,031</td></tr></table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Convertible Note - February 6, 2017</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">265,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">265,750</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Convertible Note - July 23, 2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Convertible Note – October 1, 2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74,800</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Convertible Note – October 4, 2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Convertible Note – October 11, 2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">283,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">283,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Convertible Note – December 19, 2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">82,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">82,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Convertible Note – March 7, 2019</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">210,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,014,550</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">804,550</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Debt Discount</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(419,051</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(368,373</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">595,499</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">436,177</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr></table>

9781

7511

104250

150445

114031

157956

804550

265750

25000

74800

73500

283500

82000

1014550

265750

25000

74800

73500

283500

82000

210000

368373

419051

436177

595499

216729

333460

173854 173854

26748

20589

18983

436314

546886

1101853

1168852

69330

155752

692071

734179

2756 2756

1075

1222186

1253732

2850401 2850401

6267426

4851348

12643275

11613594

12643275

11613594

2033000

3905201

4070747

21820069

22500405

-39965231

-39670860

436314

546886

10000000

3905200946

4070747508

6159

18893

150000

135244 1519057

-815970

-154002 -4500

245775

151971

126112

43925

-10071

-6918

-137641

109107

358431

86422

-431

-127194

-81438

200000

72806

-81438

13755

25500

845883 4070747508

Earnings per Share   Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents.    The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income (loss) attributable to common stockholders per common share.        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt">Numerator:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 10pt; text-indent: -10pt">Net income/(loss) attributable to common stockholders</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">294,370</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">879,905</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 30pt; text-indent: -10pt">Effect of dilutive securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 30pt; text-indent: -10pt">Convertible note - Interest Expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,241</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,751</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 30pt; text-indent: -10pt">Change in Warrant liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(815,970</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 30pt; text-indent: -10pt">Net Change in derivative liabilities - convertible payables</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(135,244</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,365,055</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt">Diluted net income (loss)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(636,603</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(476,399</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-indent: -10pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-indent: -10pt">Weighted average common shares outstanding - basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,043,156,414</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,878,730,874</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 20pt; text-indent: -10pt">Dilutive securities (a):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Series A Preferred</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Series B Preferred</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,070,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,967,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Convertible notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">738,212,072</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">128,586,957</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Convertible accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">330,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">346,554,654</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,615,879,300</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 20pt; text-indent: -10pt">Weighted average common shares outstanding and assumed conversion - diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,797,250,837</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,320,872,536</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 20pt; text-indent: -10pt">Basic net income (loss) per common share</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.00</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.00</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 20pt; text-indent: -10pt; padding-bottom: 4pt">Diluted net loss per common share</td><td style="padding-bottom: 4pt"> </td> <td style="text-align: left; border-bottom: Black 4pt double">$</td><td style="text-align: right; border-bottom: Black 4pt double">(0.00</td><td style="text-align: left; padding-bottom: 4pt">)</td><td style="padding-bottom: 4pt"> </td> <td style="text-align: left; border-bottom: Black 4pt double">$</td><td style="text-align: right; border-bottom: Black 4pt double">(0.00</td><td style="text-align: left; padding-bottom: 4pt">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt">(a) - Anti-dilutive securities excluded:</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">9,067,645</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">261,835,149</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr></table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt">Numerator:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 10pt; text-indent: -10pt">Net income/(loss) attributable to common stockholders</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">294,370</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">879,905</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 30pt; text-indent: -10pt">Effect of dilutive securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 30pt; text-indent: -10pt">Convertible note - Interest Expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">146,353</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,751</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 30pt; text-indent: -10pt">Net Change in derivative liabilities - convertible payables</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(135,244</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,365,055</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt">Diluted net income (loss)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">305,479</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(476,399</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-indent: -10pt">Weighted average common shares outstanding - basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,043,156,414</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,878,730,874</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 20pt; text-indent: -10pt">Dilutive securities (a):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Series A Preferred</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Series B Preferred</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,070,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,967,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Convertible notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">691,424,353</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">128,586,957</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Convertible accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">346,554,654</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,343,120,568</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 20pt; text-indent: -10pt">Weighted average common shares outstanding and assumed conversion - diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,150,701,386</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,320,872,536</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 20pt; text-indent: -10pt">Basic net income (loss) per common share</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 20pt; text-indent: -10pt; padding-bottom: 4pt">Diluted net loss per common share</td><td style="padding-bottom: 4pt"> </td> <td style="text-align: left; border-bottom: Black 4pt double">$</td><td style="text-align: right; border-bottom: Black 4pt double">0</td><td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: left; border-bottom: Black 4pt double">$</td><td style="text-align: right; border-bottom: Black 4pt double">(0</td><td style="text-align: left; padding-bottom: 4pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt">(a) - Anti-dilutive securities excluded:</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">2,366,340</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">261,835,149</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>

-815970

200000

30000

75000 74800 0.30

65000

68500

157000

90000

270905432

211267000

532000000

299000000

P0Y0M170D

P0Y0M180D

The maturity date of the Geneva Note is October 1, 2019 (the "Geneva Maturity Date"). The Geneva Note shall bear interest at a rate of ten percent (10%) per annum (the "Geneva Interest Rate"), which interest shall be paid by the Company to Geneva in shares of common stock at any time Geneva sends a notice of conversion to the Company. Geneva is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the Geneva Note into shares of the Company's common stock, at any time after March 20, 2019, at a conversion price for each share of common stock equal to 71% multiplied by the average of the lowest three (3) trading prices (as defined in the Geneva Purchase Agreement) for the common stock during the fifteen (15) Trading Day period (as defined in the Geneva Purchase Agreement) ending on the latest complete trading day prior to the conversion date.

Effective December 19, 2018 the Company entered into a securities purchase agreement (the "GSC Purchase Agreement") with GS Capital Partners LLC, ("GSC", and together with Geneva, the "Investors"), pursuant to which GSC purchased a 8% unsecured convertible promissory note from the Company in the aggregate principal amount of $82,000 (the "GSC Note"), such principal and the interest thereon convertible into shares of the Company's common stock at the option of GSC. The purchase price of $82,000 of the GSC Note was paid in cash by GSC on December 19, 2018. After payment of transaction-related expenses, net proceeds to the Company from the First GSC Note totaled $76,000. The maturity date of the GSC Note is December 19, 2019 (the "the GSC Maturity Date"). The GSC Note shall bear interest at a rate of eight percent (8%) per annum (the "GSC Interest Rate"), which interest shall be paid by the Company to GSC in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company's common stock, at any time, at the conversion price specified in the for each share of common stock equal to 67% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note, the Company recorded a $76,000 debt discount. The GSC Note may be prepaid until 180 days from the issuance date in accordance with its terms. The Company shall reserve 211,267,000 of its authorized and unissued common stock (the "GSC Reserved Amount"), free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of the GSC Note.

The maturity date of the GSC Note is October 4, 2019 (the "the GSC Maturity Date"). The GSC Note shall bear interest at a rate of eight percent (8%) per annum (the "GSC Interest Rate"), which interest shall be paid by the Company to GSC in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company's common stock, at any time, at the conversion price specified in the for each share of common stock equal to 71% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note the Company recorded a $58,855 debt discount.

The purchase price of $181,500, and of $102,000, of the Eagle Note and the GSC Note, respectively, was paid in cash by the Investors on October 11, 2018. After payment of transaction-related expenses, net proceeds to the Company from the Eagle Note and the GSC Note totaled $157,000 and $90,000, respectively. The maturity date of the Notes is October 11, 2019 (the "Maturity Date"). The Notes shall bear interest at a rate of eight percent (8%) per annum (the "Interest Rate"), which interest shall be paid by the Company to the Investors in shares of common stock at any time Eagle or GSC sends a notice of conversion to the Company (the "Notice of Conversion"). The Investors are entitled to, at their option, convert all or any amount of the principal face amount and any accrued but unpaid interest of their respective Notes into shares of the Company's common stock, at any time, at a conversion price for each share of common stock equal to 65% multiplied by the lowest closing bid price of the common stock as reported on the marketplace upon which the Company's shares are traded during the fifteen (15) trading day period ending on the day upon which a Notice of Conversion is received by the Company. In connection with this note, the Company recorded a $149,702 and $85,085 debt discounts.

Effective March 7, 2019 the Company entered into a securities purchase agreement with GS Capital Partners, pursuant to which GSC purchased a 8% unsecured convertible promissory note from the Company in aggregate principal amount of $210,000, such principal and interest thereon convertible into shares of the Company's common stock at the option of GSC. The purchase price of $210,000 of the GS Capital note was paid in cash by GS Capital on March 11, 2019. After payment of transaction-related expenses, net proceeds to the Company from the note totaled $200,000. The maturity date of the GS Capital note is March 7, 2020. The GS Capital Note shall bear interest at a rate of eight percent (8%) per annum which interest shall be paid by the Company to GS Capital in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company's common stock, at any time, at the conversion price specified in the for each share of common stock equal to 65% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note, the Company recorded a $167,296 debt discount.

48500

155086

295750

60000

1500

165546562 845882 165546 680336

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><td style="width: 48px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">4.</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Summary of Significant Accounting Policies</td></tr> </table>   Basis of Presentation - Unaudited Interim Financial Information   The accompanying unaudited interim condensed consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the "SEC") with respect to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company's annual report on Form 10-K for the year ended December 31, 2018.   Use of Estimates   The preparation of the consolidated finance statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Such management estimates include allowance for doubtful accounts, estimates of product returns, warranty expense, inventory valuation, valuation allowances of deferred taxes, stock-based compensation expenses and fair value of warrants and derivatives. The Company bases its estimates on historical experience and on assumptions that it believes are reasonable. The Company assesses these estimates on a regular basis; however, actual results could materially differ from those estimates.    Concentration of Risk Related to Third-party Suppliers   We depend on a limited number of third-party suppliers for the materials and components required to manufacture our products. A delay or interruption by our suppliers may harm our business, results of operations, and financial condition, and could also adversely affect our future profit margins. In addition, the lead time needed to establish a relationship with a new supplier can be lengthy, and we may experience delays in meeting demand in the event we must change or add new suppliers. Our dependence on our suppliers exposes us to numerous risks, including but not limited to the following: our suppliers may cease or reduce production or deliveries, raise prices, or renegotiate terms; we may be unable to locate a suitable replacement supplier on acceptable terms or on a timely basis, or at all; and delays caused by supply issues may harm our reputation, frustrate our customers, and cause them to turn to our competitors for future needs.    Fair Value of Financial Instruments   The Company recognizes and discloses the fair value of its assets and liabilities using a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). Each level of input has different levels of subjectivity and difficulty involved in determining fair value.   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 48px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="width: 8%; text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Level 1</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurable date.</td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Level 2</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Inputs, other than quoted prices included in Level 1, that are observable for the asset or liability through corroboration with market data at the measurement date.</td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Level 3</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Unobservable inputs that reflect management's best estimate of what participants would use in pricing the asset or liability at the measurement date.</td></tr> </table>   The carrying amounts of the Company's financial assets and liabilities, including cash, accounts receivable, accounts payable, and accrued liabilities approximate fair value because of the short maturity of these instruments. The carrying value of the Company's loan payable and convertible notes payable approximates fair value based upon borrowing rates currently available to the Company for loans with similar terms.    Business Segments   ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company's condensed consolidated financial statements as substantially all of the Company's operations are conducted in one industry segment.   Cash   The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. As of March 31, 2019 and December 31, 2018, the Company held no cash equivalents.   The Company's policy is to place its cash with high credit quality financial instruments and institutions and limit the amounts invested with any one financial institution or in any type of instrument. Deposits held with banks may exceed the amount of insurance provided on such deposits. The Company has not experienced any losses on its deposits of cash.   Accounts Receivable and Allowance for Doubtful Accounts   Accounts receivable are recorded at the invoiced amount and are not interest bearing. The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. The Company makes ongoing assumptions relating to the collectability of its accounts receivable in its calculation of the allowance for doubtful accounts. In determining the amount of the allowance, the Company makes judgments about the creditworthiness of customers based on ongoing credit evaluations and assesses current economic trends affecting its customers that might impact the level of credit losses in the future and result in different rates of bad debts than previously seen. The Company also considers its historical level of credit losses. As of March 31, 2019 and December 31, 2018, there was an allowance for doubtful accounts of $27,851 and $27,851 respectively.   During the three months ended March 31, 2019 and 2018 the Company recorded a bad debt expense of $0 and $0, respectively.   Inventory   Inventory is stated at the lower of cost or market value. Inventory is determined to be salable based on demand forecast within a specific time horizon, generally eighteen months or less. Inventory in excess of salable amounts and inventory which is considered obsolete based upon changes in existing technology is written off. At the point of recognition, a new lower cost basis for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in that new cost basis.    Property and Equipment   Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the useful life as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="width: 51%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Internal-use software</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="width: 48%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">3 years</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Equipment</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">3 to 5 years</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Computer equipment</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">3 to 7 years</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Furniture and fixtures</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">5 to 7 years</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Leasehold improvements</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Shorter of life of asset or lease</td></tr> </table>   Accounting for Website Development Costs   The Company capitalizes certain external and internal costs, including internal payroll costs, incurred in connection with the development of its website. These costs are capitalized beginning when the Company has entered the application development stage and cease when the project is substantially complete and is ready for its intended use. The website development costs are amortized using the straight-line method over the estimated useful life of three years.   Impairment of Long-Lived Assets   Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of would be separately presented in the balance sheets and reported at the lower of the carrying amount or fair value less costs to sell, and no longer depreciated. The assets and liabilities of a disposed group classified as held for sale would be presented separately in the appropriate asset and liability sections of the balance sheets.   Debt Discount and Debt Issuance Costs   Debt discounts and debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense based on the related debt agreements using the straight-line method. Unamortized discounts are netted against long-term debt.   Derivative Liability   In accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Paragraph 815-15-25-1 the conversion feature and certain other features are considered embedded derivative instruments, such as a conversion reset provision, a penalty provision and redemption option, which are to be recorded at their fair value as its fair value can be separated from the convertible note and its conversion is independent of the underlying note value. The Company records the resulting discount on debt related to the conversion features at initial transaction and amortizes the discount using the effective interest rate method over the life of the debt instruments. The conversion liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations.   In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.    The Company follows ASC Section 815-40-15 ("Section 815-40-15") to determine whether an instrument (or an embedded feature) is indexed to the Company's own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument's contingent exercise and settlement provisions. The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.   The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.    The Company utilizes the binomial option pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The binomial option pricing model includes subjective input assumptions that can materially affect the fair value estimates. The expected volatility is estimated based on the most recent historical period of time equal to the remaining contractual term of the instrument granted.   Revenue Recognition   The Company adopted ASC 606 effective January 1, 2018 using the modified retrospective method which would require a cumulative effect adjustment for initially applying the new revenue standard as an adjustment to the opening balance of retained earnings and the comparative information would not require to be restated and continue to be reported under the accounting standards in effect for those periods.   Based on the Company's analysis the Company did not identify a cumulative effect adjustment for initially applying the new revenue standards. The Company principally generates revenue through providing product, services and licensing revenue   The adoption of ASC 606 represents a change in accounting principle that will more closely align revenue recognition with the delivery of the Company's services and will provide financial statement readers with enhanced disclosures. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. To achieve this core principle, the Company applies the following five steps:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 34px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">1)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Identify the contract with a customer</td></tr> </table>   A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party's rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for services that are transferred is probable based on the customer's intent and ability to pay the promised consideration. The Company applies judgment in determining the customer's ability and intention to pay, which is based on a variety of factors including the customer's historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.    <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 34px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">2)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Identify the performance obligations in the contract</td></tr> </table>   Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services, the Company must apply judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met the promised services are accounted for as a combined performance obligation.   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 34px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">3)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Determine the transaction price</td></tr> </table>   The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring services to the customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Company's judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company's contracts as of December 31, 2018 contained a significant financing component. Determining the transaction price requires significant judgment, which is discussed by revenue category in further detail below.   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 34px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">4)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Allocate the transaction price to performance obligations in the contract</td></tr> </table>   If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series of distinct services that are substantially the same qualifies as a single performance obligation in a contract with variable consideration, the Company must determine if the variable consideration is attributable to the entire contract or to a specific part of the contract. For example, a bonus or penalty may be associated with one or more, but not all, distinct services promised in a series of distinct services that forms part of a single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that forms part of a single performance obligation. The Company determines standalone selling price based on the price at which the performance obligation is sold separately. If the standalone selling price is not observable through past transactions, the Company estimates the standalone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 34px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">5)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Recognize revenue when or as the Company satisfies a performance obligation</td></tr> </table>   The Company satisfies performance obligations either over time or at a point in time. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised service to a customer.    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months ended March 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months ended March 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">United States</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">International</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">United States</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">International</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Product Revenue</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">494</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">757</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,251</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">39,666</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">27,178</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">66,844</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product Service Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">288</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">288</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,987</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,455</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Licensing Revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,130</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,130</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">782</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">757</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,539</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">47,264</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">29,165</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">76,429</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>    Product revenue   Revenue from multiple-element arrangements is allocated among separate elements based on their estimated sales prices, provided the elements have value on a stand-alone basis.   Licensing revenue   Some of the Company's revenues are generated from software-as-a-service ("SaaS") subscription offerings and related product support and maintenance. SaaS revenues stem mainly from annual subscriptions and are recorded evenly over the term of the subscription. Any customer payments received in advance are deferred until they are earned. Consulting and training revenues are recognized as work is performed.   Warranty   The Company provides a limited warranty for its analyzers and sensors for a period of 1 year from the date of shipment that such goods will be free from material defects in material and workmanship. The Company has assessed the historical claims and, to date, warranty claims have not been significant. The Company will continue to assess the need to record a warranty accrual at the time of sale going forward.   Product Returns   For any product in its original, undamaged and unmarked condition, with its included accessories and packaging along with the original receipt (or gift receipt) within 30 days of the date the customer receives the product, the Company will exchange it or offer a refund based upon the original payment method.   Customer Deposits   The Company accounts for funds received from crowdfunding campaigns and pre-sales as a liability on the consolidated balance sheets as the investments made entitle the investor to apply these funds towards future shipments once the product has been developed and available for commercial use.     Research and Development Costs   Research and development costs are charged to expense as incurred. These costs consist primarily of salaries and direct payroll-related costs. It also includes purchased materials and services provided by independent contractors, software developed by other companies and incorporated into or used in the development of our final products. Research and development expenses for the three months ended March 31, 2019 and 2018 were $13,935 and $233,090, respectively.   Advertising Costs   Advertising costs are charged to sales and marketing expenses and general and administrative expenses as incurred. Advertising expenses, which are recorded in sales and marketing and general and administrative expenses, totaled $54,290 and $37,253 for the three months ended March 31, 2019 and 2018, respectively.    Stock-Based Compensation   The Company accounts for stock-based compensation in accordance with ASC Topic 718, "Compensation – Stock Compensation" ("ASC 718") which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value-based method of accounting for an employee stock option or similar equity instrument. Accordingly, stock-based compensation is recognized in the consolidated statements of operations as an operating expense over the requisite service period. The Company uses the Black-Scholes option pricing model adjusted for the estimated forfeiture rate for the respective grant to determine the estimated fair value of stock-based compensation arrangements on the date of grant and expenses this value ratably over the requisite service period of the stock option. The Black-Scholes option pricing model requires the input of highly subjective assumptions. Because the Company's stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's opinion, the existing models may not provide a reliable single measure of the fair value of the Company's stock options. In addition, management will continue to assess the assumptions and methodologies used to calculate estimated fair value of stock-based compensation. Circumstances may change and additional data may become available over time, which could result in changes to these assumptions and methodologies for future grants, and which could materially impact the Company's fair value determination.    Collaborative Arrangements   The Company and its collaborative partners are active participants in the collaborative arrangements and both parties are exposed to significant risks and rewards depending on the commercial success of the activity. The Company records all expenses related to collaborative arrangements as research and development expense in the consolidated statements of operations as incurred.    Earnings per Share   Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents.    The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income (loss) attributable to common stockholders per common share.        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-indent: -10pt">Numerator:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 10pt; text-indent: -10pt">Net income/(loss) attributable to common stockholders</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">294,370</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">879,905</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 30pt; text-indent: -10pt">Effect of dilutive securities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 30pt; text-indent: -10pt">Convertible note - Interest Expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,241</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,751</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 30pt; text-indent: -10pt">Change in Warrant liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(815,970</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 30pt; text-indent: -10pt">Net Change in derivative liabilities - convertible payables</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(135,244</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,365,055</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt">Diluted net income (loss)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(636,603</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(476,399</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-indent: -10pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-indent: -10pt">Weighted average common shares outstanding - basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,043,156,414</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,878,730,874</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 20pt; text-indent: -10pt">Dilutive securities (a):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Series A Preferred</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Series B Preferred</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,070,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,967,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Convertible notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">738,212,072</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">128,586,957</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Convertible accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">330,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">346,554,654</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 40pt; text-indent: -10pt">Warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,615,879,300</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 20pt; text-indent: -10pt">Weighted average common shares outstanding and assumed conversion - diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,797,250,837</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,320,872,536</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 20pt; text-indent: -10pt">Basic net income (loss) per common share</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.00</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.00</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 20pt; text-indent: -10pt; padding-bottom: 4pt">Diluted net loss per common share</td><td style="padding-bottom: 4pt"> </td> <td style="text-align: left; border-bottom: Black 4pt double">$</td><td style="text-align: right; border-bottom: Black 4pt double">(0.00</td><td style="text-align: left; padding-bottom: 4pt">)</td><td style="padding-bottom: 4pt"> </td> <td style="text-align: left; border-bottom: Black 4pt double">$</td><td style="text-align: right; border-bottom: Black 4pt double">(0.00</td><td style="text-align: left; padding-bottom: 4pt">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt">(a) - Anti-dilutive securities excluded:</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">9,067,645</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">261,835,149</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>   Recent Accounting Guidance Adopted   In February 2016, the FASB issued ASU 2016-02 "Leases" (Topic 842) which amended guidance for lease arrangements to increase transparency and comparability by providing additional information to users of financial statements regarding an entity's leasing activities. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as ASC 842. The revised guidance seeks to achieve this objective by requiring reporting entities to recognize lease assets and lease liabilities on the balance sheet for substantially all lease arrangements.   On January 1, 2019, the Company adopted ASC 842 using the modified retrospective approach. Results for the three months ended March 31, 2019 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the legacy accounting guidance under ASC Topic 840, Leases.   As part of the adoption we elected the practical expedients permitted under the transition guidance within the new standard, which among other things, allowed us to:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 24px; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="width: 24px; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">1.</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">Continue applying our current policy for accounting for land easements that existed as of, or expired before, January 1, 2019.</td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"> </td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">2.</td> <td style="padding: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0">Not separate non-lease components from lease components and instead to account for each separate lease component and the non-lease components associated with that lease component as a single lease component.</td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">3.</td> <td style="padding: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0">Not to apply the recognition requirements in ASC 842 to short-term leases.</td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td></tr> <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"> </td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">4.</td> <td style="padding: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0">Not record a right of use asset or right of use liability for leases with an asset or liability balance that would be considered immaterial.</td></tr></table>

EX-101.SCH 6 mydx-20190331.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Stockholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Nature of Business link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Derivative Liabilities link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Derivative Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Going Concern (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Summary of Significant Accounting Policies (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Summary of Significant Accounting Policies (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Summary of Significant Accounting Policies (Details Textual) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Debt (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Debt (Details Textual) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Derivative Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Derivative Liabilities (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Derivative Liabilities (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Derivative Liabilities (Details Textual) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Stockholders' Deficit (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Subsequent Events (Details Textual) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 mydx-20190331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 mydx-20190331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 mydx-20190331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Property, Plant and Equipment, Type [Axis] Software Development [Member] Equipment [Member] Range [Axis] Minimum [Member] Maximum [Member] Computer Equipment [Member] Furniture and Fixtures [Member] Leasehold Improvements [Member] Warrant [Member] Short-term Debt, Type [Axis] Convertible Accounts Payable [Member] Convertible Notes Payable [Member] Options [Member] Income Statement Location [Axis] Selling and Marketing Expense [Member] General and Administrative Expense [Member] Convertible Notes Payable One [Member] Convertible Notes Payable Two [Member] Convertible Notes Payable Three [Member] Convertible Notes Payable Four [Member] Convertible Notes Payable Five [Member] Related Party [Axis] Lenders [Member] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Financial Instrument [Axis] Derivative [Member] Common Stock [Member] Derivative Instrument [Axis] Fair Value Of Derivative Liability And Warrant Liability [Member] ArrangementTypeAxis [Axis] Note purchase agreement [Member] Agreement [Axis] Geneva Securities Purchase Agreement [Member] GSC Purchase Agreement [Member] GS Capital Securities Purchase Agreement [Member] Eagle Purchase Agreement [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Product and Service [Axis] Product revenue [Member] Geographical [Axis] United States [Member] International [Member] Product service revenue [Member] Licensing revenue [Member] Redeemable Series B Preferred stock Convertible Note - March 7, 2019 [Member] LG Capital Funding, LLC [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Odyssey Capital Funding, LLC [Member] Hasper Inc [Member] Amendment [Member] Series A Preferred [Member] Eagle and GSC Securities Purchase Agreements [Member] GS Capital Partners [Member] Document and Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Trading Symbol Amendment Flag Current Fiscal Year End Date Document Type Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Entity Filer Category Entity Transition Period Entity Small Business Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Statement of Financial Position [Abstract] ASSETS Current assets: Cash Inventory Total current assets Tooling in process Property and equipment, net Other assets Total assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Accounts payable Customer deposits Accrued liabilities Current portion of leases payable Due to related party Convertible notes payable, current, net of debt discount Derivative liability Preferred shares liability Warrant liability Total current liabilities Total liabilities Redeemable Series B Preferred stock, $0.001 par value; 10,000,000 shares authorized 107,000 and 107,000 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively Commitments and contingencies Stockholders' deficit: Series A Preferred stock, $0.001 par value; 51 shares authorized 51 and 51 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively Common stock, $0.001 par value, 10,000,000,000 shares authorized; 4,070,747,508 and 3,905,200,946 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively Additional paid-in capital Accumulated deficit Total stockholders' deficit Total liabilities and stockholders' deficit Statement [Table] Statement [Line Items] Series A Preferred stock Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Sales Product revenue Product service revenue Licensing revenue Total sales Cost of goods sold Product costs Total cost of sales Gross profit Operating Expenses Research and development Sales and marketing General and administrative Total operating expenses Loss from operations Other income (expense) Interest expense, net Change in fair value of derivative liability Change in fair value of warrant liability Derivative expense Gain on settlement of debt Total Other income (expense) Income before provision for income taxes Provision for income taxes Net Income Dividends Net Income attributable to common shareholders Loss per share Basic Diluted Weighted average common shares outstanding - basic Weighted average common shares outstanding - diluted Convertible Preferred Stock Series A Common Stock Additional Paid-in Capital Accumulated Deficit Balance Balance, Shares Issuance of common stock upon cashless exercise of warrants Issuance of common stock upon cashless exercise of warrants, shares Issuance of common stock for services rendered Issuance of common stock for services rendered, Shares Common stock issued to settle vendor liabilities Common stock issued to settle vendor liabilities, Shares Stock based compensation Net income Balance Balance, Shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net income Adjustments to reconcile net income to net cash used in operating activities: Depreciation and amortization Common stock issued in exchange for services Change in fair value of derivative liability Change in fair value of warrant liability Derivative expense Gain on settlement of vendor liabilities Stock based compensation Interest expense related to amortization of debt issuance costs and debt discount Changes in assets and liabilities: Inventory Prepaid expenses and other assets Tooling in process Accounts payable and accrued liabilities Customer deposits Net cash used in operating activities Cash flows from financing activities Proceeds from note payable, net of issuance costs Net cash provided by financing activities Net change in cash Cash, beginning of period Cash, end of period EX-101.PRE 10 mydx-20190331_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2019	Jun. 07, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	MyDx, Inc.
Entity Central Index Key	0001582341
Trading Symbol	MYDX
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2019
Entity Filer Category	Non-accelerated Filer
Entity Transition Period	false
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Common Stock, Shares Outstanding		4,070,747,508

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash	$ 175,504	$ 102,698
Inventory	157,956	114,031
Total current assets	333,460	216,729
Tooling in process	173,854	173,854
Property and equipment, net	20,589	26,748
Other assets	18,983	18,983
Total assets	546,886	436,314
Current liabilities:
Accounts payable	1,168,852	1,101,853
Customer deposits	155,752	69,330
Accrued liabilities	734,179	692,071
Current portion of leases payable	2,756	2,756
Due to related party	1,075	1,075
Convertible notes payable, current, net of debt discount	595,499	436,177
Derivative liability	1,253,732	1,222,186
Preferred shares liability	2,850,401	2,850,401
Warrant liability	4,851,348	6,267,426
Total current liabilities	11,613,594	12,643,275
Total liabilities	11,613,594	12,643,275
Redeemable Series B Preferred stock, $0.001 par value; 10,000,000 shares authorized 107,000 and 107,000 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively	2,033,000	2,033,000
Commitments and contingencies
Stockholders' deficit:
Series A Preferred stock, $0.001 par value; 51 shares authorized 51 and 51 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively
Common stock, $0.001 par value, 10,000,000,000 shares authorized; 4,070,747,508 and 3,905,200,946 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively	4,070,747	3,905,201
Additional paid-in capital	22,500,405	21,820,069
Accumulated deficit	(39,670,860)	(39,965,231)
Total stockholders' deficit	(13,099,708)	(14,239,961)
Total liabilities and stockholders' deficit	$ 546,886	$ 436,314

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2019	Dec. 31, 2018
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	10,000,000,000	10,000,000,000
Common stock, shares issued	4,070,747,508	3,905,200,946
Common stock, shares outstanding	4,070,747,508	3,905,200,946
Redeemable Series B Preferred stock
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	107,000	107,000
Preferred stock, shares outstanding	107,000	107,000
Series A Preferred stock
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	51	51
Preferred stock, shares issued	51	51
Preferred stock, shares outstanding	51	51

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Sales
Product revenue	$ 1,251	$ 66,844
Product service revenue	288	5,455
Licensing revenue		4,130
Total sales	1,539	76,429
Cost of goods sold
Product costs	16,883	26,338
Total cost of sales	16,883	26,338
Gross profit	(15,344)	50,091
Operating Expenses
Research and development	13,935	233,090
Sales and marketing	54,290	52,253
General and administrative	426,922	245,647
Total operating expenses	495,147	530,990
Loss from operations	(510,491)	(480,899)
Other income (expense)
Interest expense, net	(146,353)	(8,751)
Change in fair value of derivative liability	135,244	1,519,057
Change in fair value of warrant liability	815,970
Derivative expense		(154,002)
Gain on settlement of debt		4,500
Total Other income (expense)	804,861	1,360,804
Income before provision for income taxes	294,370	879,905
Provision for income taxes
Net Income	294,370	879,905
Dividends	10,700
Net Income attributable to common shareholders	$ 879,905	$ 283,670
Loss per share
Basic	$ (0.00)	$ 0
Diluted	$ (0.00)	$ 0
Weighted average common shares outstanding - basic	4,043,156,414	1,878,730,874
Weighted average common shares outstanding - diluted	7,797,250,837	5,320,872,536

XML 15 R5.htm IDEA: XBRL DOCUMENT

Statements of Stockholders' Deficit (Unaudited) - USD ($)	Convertible Preferred Stock Series A	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2017		$ 1,859,397	$ 19,818,536	$ (31,632,972)	$ (14,239,961)
Balance, Shares at Dec. 31, 2017	51	1,859,397,541
Issuance of common stock for services rendered		$ 30,000	120,000		150,000
Issuance of common stock for services rendered, Shares		30,000,000
Common stock issued to settle vendor liabilities		$ 5,000	20,500		25,500
Common stock issued to settle vendor liabilities, Shares		5,000,000
Stock based compensation			1,971		1,971
Net income				879,905	283,670
Balance at Mar. 31, 2018		$ 1,894,397	19,961,007	(30,753,067)	(13,099,708)
Balance, Shares at Mar. 31, 2018	51	1,894,397,541
Balance at Dec. 31, 2018		$ 3,905,201	21,820,069	(39,965,231)	(14,239,961)
Balance, Shares at Dec. 31, 2018	51	3,905,200,946
Issuance of common stock upon cashless exercise of warrants		$ 165,546	680,336		845,882
Issuance of common stock upon cashless exercise of warrants, shares		165,546,562
Net income				294,370	879,905
Balance at Mar. 31, 2019		$ 4,070,747	$ 22,500,405	$ (39,670,860)	$ (13,099,708)
Balance, Shares at Mar. 31, 2019	51	4,070,747,508

XML 16 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income	$ 294,370	$ 879,905
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	6,159	18,893
Common stock issued in exchange for services		150,000
Change in fair value of derivative liability	(135,244)	(1,519,057)
Change in fair value of warrant liability	(815,970)
Derivative expense		154,002
Gain on settlement of vendor liabilities		(4,500)
Stock based compensation	245,775	151,971
Interest expense related to amortization of debt issuance costs and debt discount	126,112
Changes in assets and liabilities:
Inventory	(43,925)	10,071
Prepaid expenses and other assets		6,918
Tooling in process		(137,641)
Accounts payable and accrued liabilities	109,107	358,431
Customer deposits	86,422	(431)
Net cash used in operating activities	(127,194)	(81,438)
Cash flows from financing activities
Proceeds from note payable, net of issuance costs	200,000
Net cash provided by financing activities	200,000
Net change in cash	72,806	(81,438)
Cash, beginning of period	102,698	119,028
Cash, end of period	175,504	37,590
Supplemental cash flow information:
Interest paid		13,755
Taxes paid
Supplemental disclosure of non-cash investing and financing activities:
Stock issued for settlement of vendor liabilities		25,500
Reclassification of warrant liability to additional paid-in capital upon exercise of warrant	$ 845,883

XML 17 R7.htm IDEA: XBRL DOCUMENT

Organization

3 Months Ended

Mar. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization

1.	Organization

MyDx, Inc. (the "Company", "we", "us" or "our") (formally known as Brista Corp.) was incorporated under the laws of the State of Nevada on December 20, 2012. The Company's wholly owned subsidiary, CDx, Inc., was incorporated under the laws of the State of Delaware on September 16, 2013.

XML 18 R8.htm IDEA: XBRL DOCUMENT

Nature of Business

3 Months Ended

Mar. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Business

2.	Nature of Business

MyDx is a science and technology company that develops and deploys products and services in the following focus areas:

Consumer Products – smart devices and consumables

Data Analytics – pre-clinical chemical analysis and patient feedback ecosystem

Biopharmaceuticals – identifying 'green Active Pharmaceutical Ingredients^TM, (gAPI^TM) and corresponding formulations

Software as a Service (SaaS) – Software services for prescribers, patient groups, cultivators, and regulators

We are committed to addressing areas of critical national need to promote public safety, transparency and regulation in the various markets we serve.

The Company's first product, MyDx^®, also known as "My Diagnostic", is a patented multiuse hand-held chemical analyzer made for consumers and professional users which feeds our data analytics platform and SaaS business. MyDx is intended to allow consumers to Trust & Verify^® what they put into their mind and body by using our science and technology to test for pesticides in food, chemicals in water, toxins in the air, and the safety and potency of cannabis samples, which is our initial focus.

XML 19 R9.htm IDEA: XBRL DOCUMENT

Going Concern

3 Months Ended

Mar. 31, 2019

Going Concern [Abstract]

Going Concern

3.	Going Concern

The Company's condensed consolidated financial statements have been prepared assuming it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

The Company is attempting to further implement its business plan and generate sufficient revenues; however, its cash position may not be sufficient to support its daily operations. The Company has a limited operating history and its prospects are subject to risks, expenses and uncertainties frequently encountered by early-stage companies. These risks include, but are not limited to, the uncertainty of availability of financing and the uncertainty of achieving future profitability. Management anticipates that the Company will be dependent, for the near future, on investment capital to fund operating expenses. The Company intends to position itself so that it may be able to raise funds through the capital markets. There can be no assurance that such financing will be available at terms acceptable to the Company, if at all. Failure to generate sufficient cash flows from operations, raise capital or reduce certain discretionary spending could have a material adverse effect on the Company's ability to achieve its intended business objectives. We reported negative cash flow from operations for the three months ended March 31, 2019. It is anticipated that we will continue to report negative operating cash flow in future periods, likely until one or more of our products generate sufficient revenue to cover our operating expenses. If any of the warrants are exercised, all net proceeds of the warrant exercise will be used for working capital to fund negative operating cash flow.

XML 20 R10.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

4.	Summary of Significant Accounting Policies

Basis of Presentation - Unaudited Interim Financial Information

The accompanying unaudited interim condensed consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the "SEC") with respect to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company's annual report on Form 10-K for the year ended December 31, 2018.

Use of Estimates

Concentration of Risk Related to Third-party Suppliers

Fair Value of Financial Instruments

	Level 1	Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurable date.

	Level 2	Inputs, other than quoted prices included in Level 1, that are observable for the asset or liability through corroboration with market data at the measurement date.

	Level 3	Unobservable inputs that reflect management's best estimate of what participants would use in pricing the asset or liability at the measurement date.

The carrying amounts of the Company's financial assets and liabilities, including cash, accounts receivable, accounts payable, and accrued liabilities approximate fair value because of the short maturity of these instruments. The carrying value of the Company's loan payable and convertible notes payable approximates fair value based upon borrowing rates currently available to the Company for loans with similar terms.

Business Segments

ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company's condensed consolidated financial statements as substantially all of the Company's operations are conducted in one industry segment.

Cash

The Company's policy is to place its cash with high credit quality financial instruments and institutions and limit the amounts invested with any one financial institution or in any type of instrument. Deposits held with banks may exceed the amount of insurance provided on such deposits. The Company has not experienced any losses on its deposits of cash.

Accounts Receivable and Allowance for Doubtful Accounts

During the three months ended March 31, 2019 and 2018 the Company recorded a bad debt expense of $0 and $0, respectively.

Inventory

Property and Equipment

Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the useful life as follows:

Internal-use software		3 years
Equipment		3 to 5 years
Computer equipment		3 to 7 years
Furniture and fixtures		5 to 7 years
Leasehold improvements		Shorter of life of asset or lease

Accounting for Website Development Costs

Impairment of Long-Lived Assets

Debt Discount and Debt Issuance Costs

Derivative Liability

In accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Paragraph 815-15-25-1 the conversion feature and certain other features are considered embedded derivative instruments, such as a conversion reset provision, a penalty provision and redemption option, which are to be recorded at their fair value as its fair value can be separated from the convertible note and its conversion is independent of the underlying note value. The Company records the resulting discount on debt related to the conversion features at initial transaction and amortizes the discount using the effective interest rate method over the life of the debt instruments. The conversion liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations.

The Company follows ASC Section 815-40-15 ("Section 815-40-15") to determine whether an instrument (or an embedded feature) is indexed to the Company's own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument's contingent exercise and settlement provisions. The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.

Revenue Recognition

Based on the Company's analysis the Company did not identify a cumulative effect adjustment for initially applying the new revenue standards. The Company principally generates revenue through providing product, services and licensing revenue

The adoption of ASC 606 represents a change in accounting principle that will more closely align revenue recognition with the delivery of the Company's services and will provide financial statement readers with enhanced disclosures. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. To achieve this core principle, the Company applies the following five steps:

1)	Identify the contract with a customer

A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party's rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for services that are transferred is probable based on the customer's intent and ability to pay the promised consideration. The Company applies judgment in determining the customer's ability and intention to pay, which is based on a variety of factors including the customer's historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.

2)	Identify the performance obligations in the contract

3)	Determine the transaction price

The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring services to the customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Company's judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company's contracts as of December 31, 2018 contained a significant financing component. Determining the transaction price requires significant judgment, which is discussed by revenue category in further detail below.

4)	Allocate the transaction price to performance obligations in the contract

5)	Recognize revenue when or as the Company satisfies a performance obligation

	Three Months ended March 31, 2019						Three Months ended March 31, 2018
	United States		International		Total		United States		International		Total
Product Revenue		494		757		1,251		39,666		27,178		66,844
Product Service Revenue		288		-		288		3,468		1,987		5,455
Licensing Revenue		-		-		-		4,130				4,130
		782		757		1,539		47,264		29,165		76,429

Product revenue

Revenue from multiple-element arrangements is allocated among separate elements based on their estimated sales prices, provided the elements have value on a stand-alone basis.

Licensing revenue

Some of the Company's revenues are generated from software-as-a-service ("SaaS") subscription offerings and related product support and maintenance. SaaS revenues stem mainly from annual subscriptions and are recorded evenly over the term of the subscription. Any customer payments received in advance are deferred until they are earned. Consulting and training revenues are recognized as work is performed.

Warranty

Product Returns

Customer Deposits

Research and Development Costs

Advertising Costs

Stock-Based Compensation

The Company accounts for stock-based compensation in accordance with ASC Topic 718, "Compensation – Stock Compensation" ("ASC 718") which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value-based method of accounting for an employee stock option or similar equity instrument. Accordingly, stock-based compensation is recognized in the consolidated statements of operations as an operating expense over the requisite service period. The Company uses the Black-Scholes option pricing model adjusted for the estimated forfeiture rate for the respective grant to determine the estimated fair value of stock-based compensation arrangements on the date of grant and expenses this value ratably over the requisite service period of the stock option. The Black-Scholes option pricing model requires the input of highly subjective assumptions. Because the Company's stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's opinion, the existing models may not provide a reliable single measure of the fair value of the Company's stock options. In addition, management will continue to assess the assumptions and methodologies used to calculate estimated fair value of stock-based compensation. Circumstances may change and additional data may become available over time, which could result in changes to these assumptions and methodologies for future grants, and which could materially impact the Company's fair value determination.

Collaborative Arrangements

Earnings per Share

The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income (loss) attributable to common stockholders per common share.

	For the Three Months Ended
	March 31, 2019			March 31, 2018
Numerator:
Net income/(loss) attributable to common stockholders	$	294,370		$	879,905
Effect of dilutive securities:		-			-
Convertible note - Interest Expense		20,241			8,751
Change in Warrant liability		(815,970	)		-
Net Change in derivative liabilities - convertible payables		(135,244	)		(1,365,055	)

Diluted net income (loss)	$	(636,603	)	$	(476,399	)

Denominator:
Weighted average common shares outstanding - basic		4,043,156,414			1,878,730,874
Dilutive securities (a):
Series A Preferred		51			51
Series B Preferred		1,070,000,000			2,967,000,000
Convertible notes payable		738,212,072			128,586,957
Convertible accounts payable		330,000,000			346,554,654
Options		-			-
Warrants		1,615,879,300			-

Weighted average common shares outstanding and assumed conversion - diluted		7,797,250,837			5,320,872,536

Basic net income (loss) per common share	$	0.00		$	0.00

Diluted net loss per common share	$	(0.00	)	$	(0.00	)

(a) - Anti-dilutive securities excluded:		9,067,645			261,835,149

Recent Accounting Guidance Adopted

In February 2016, the FASB issued ASU 2016-02 "Leases" (Topic 842) which amended guidance for lease arrangements to increase transparency and comparability by providing additional information to users of financial statements regarding an entity's leasing activities. Subsequent to the issuance of Topic 842, the FASB clarified the guidance through several ASUs; hereinafter the collection of lease guidance is referred to as ASC 842. The revised guidance seeks to achieve this objective by requiring reporting entities to recognize lease assets and lease liabilities on the balance sheet for substantially all lease arrangements.

As part of the adoption we elected the practical expedients permitted under the transition guidance within the new standard, which among other things, allowed us to:

	1.	Continue applying our current policy for accounting for land easements that existed as of, or expired before, January 1, 2019.

	2.	Not separate non-lease components from lease components and instead to account for each separate lease component and the non-lease components associated with that lease component as a single lease component.

	3.	Not to apply the recognition requirements in ASC 842 to short-term leases.

	4.	Not record a right of use asset or right of use liability for leases with an asset or liability balance that would be considered immaterial.

XML 21 R11.htm IDEA: XBRL DOCUMENT

Derivative Liabilities

3 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Liabilities

7.	Derivative Liabilities

The Company has identified derivative instruments arising from embedded conversion features in the Company’s convertible notes payable and accounts payable at March 31, 2019.

	Low			High
Annual dividend rate		0	%		0	%
Expected life in years		.32			1.00
Risk-free interest rate		2.40	%		2.44	%
Expected volatility		103	%		114	%

Risk-free interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar term on the date of the grant.

Dividend yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future.

Volatility: The volatility was estimated using the historical volatilities of the Company’s common stock.

Remaining term: The Company’s remaining term is based on the remaining contractual maturity of the convertible notes payable and accounts payable.

The following are the changes in the derivative liabilities during the three months ended March 31, 2019.

Three Months Ended March 31, 2019

Level 1

Level 2

Level 3

Derivative Liability as of January 1, 2019

1,222,186

Initial derivative expense

166,790

Gain on changes in fair value

(135,244

)

Derivative liabilities as of March 31, 2019

1,253,732

The following are the changes in the warrant liabilities during the three months ended March 31, 2019.

	Three Months Ended March 31, 2019
	Level 1		Level 2		Level 3
Balance, January 1, 2019	$	-	$	-	$	6,267,426
Change due to exercise of warrants						(845,883	)
Gain on changes in fair value		-		-		(815,970	)
Accretion of warrant expense		-		-		245,775
Warrant liabilities as March 31, 2019	$	-	$	-	$	4,851,348

XML 22 R12.htm IDEA: XBRL DOCUMENT

Inventory

3 Months Ended

Mar. 31, 2019

Inventory Disclosure [Abstract]

Inventory

5.	Inventory

Inventory as of March 31, 2019 and December 31, 2018 is as follows:

	March 31,		December 31,
	2019		2018
Finished goods	$	7,511	$	9,781
Raw materials		150,445		104,250
	$	157,956	$	114,031

XML 23 R13.htm IDEA: XBRL DOCUMENT

Debt

3 Months Ended

Mar. 31, 2019

Debt Disclosure [Abstract]

Debt

Debt

Convertible Notes

The following table shows the outstanding balance as of March 31, 2019 and December 31, 2018 respectively.

	March 31,			December 31,
	2019			2018
Convertible Note - February 6, 2017		265,750			265,750
Convertible Note - July 23, 2018		25,000			25,000
Convertible Note – October 1, 2018		74,800			74,800
Convertible Note – October 4, 2018		73,500			73,500
Convertible Note – October 11, 2018		283,500			283,500
Convertible Note – December 19, 2018		82,000			82,000
Convertible Note – March 7, 2019		210,000			-
		1,014,550			804,550
Less: Debt Discount		(419,051	)		(368,373	)
Total	$	595,499		$	436,177

Amendment 2

On December 27, 2017 the Company, Hasfer, Inc. and Legacy, entered into an amendment to the note. The note was modified as follows:

●	A portion of the outstanding principal and interest was assigned to Legacy.

●	The company received proceeds of $48,500.

●	Fees related to the amendment totaled $1,500. The fees were recorded as a loss on extinguishment of debt.

All remaining terms of the Revolving note remained the same.

During the year ended December 31, 2017 Hasfer converted $236,250 of the outstanding principal into 99,891,304 share of the company's common stock.

As of December 31, 2017 and 2016 the balance of this agreement was $295,750 and $0 respectively.

During the year ended the lenders converted $60,000 of the outstanding principal into 26,086,956 shares of the Company's common stock.

Geneva Securities Purchase Agreement

Effective October 1, 2018, the Company entered into a securities purchase agreement (the "Geneva Purchase Agreement") with Geneva Roth Remark Holdings, Inc., ("Geneva"), pursuant to which Geneva purchased a 10% unsecured convertible promissory note (the "Geneva Note") from the Company in the aggregate principal amount of $74,800, such principal and the interest thereon convertible into shares of the Company's common stock at the option of Geneva.

The Geneva Note may be prepaid until 170 days from the issuance date in accordance with its terms.

The Company shall reserve 270,905,432 of its authorized and unissued common stock (the "Geneva Reserved Amount"), free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of the Geneva Note.

GS Capital Securities Purchase Agreement

Effective October 4, 2018 the Company entered into a securities purchase agreement (the "GSC Purchase Agreement") with GS Capital Partners LLC, ("GSC", and together with Geneva, the "Investors"), pursuant to which GSC purchased a 8% unsecured convertible promissory note from the Company in the aggregate principal amount of $75,000 (the "GSC Note"), such principal and the interest thereon convertible into shares of the Company's common stock at the option of GSC.

The GSC Note may be prepaid until 180 days from the issuance date in accordance with its terms.

The Company shall reserve 211,267,000 of its authorized and unissued common stock (the "GSC Reserved Amount"), free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of the GSC Note.

Eagle and GSC Securities Purchase Agreements

Effective October 11, 2018, the Company entered into a securities purchase agreement (the "Eagle Purchase Agreement") with Eagle Equities, LLC ("Eagle"), pursuant to which Eagle purchased an 8% unsecured convertible promissory note (the "Eagle Note") from the Company in the aggregate principal amount of $181,500, such principal and the interest thereon convertible into shares of the Company's common stock at the option of Eagle.

Effective October 11, 2018 the Company entered into a securities purchase agreement (the "GSC Purchase Agreement" and together with the Eagle Purchase Agreement, the "SPAs") with GSC (together with Eagle, the "Investors"), pursuant to which GSC purchased an 8% unsecured convertible promissory note (the "GSC Note" and together with the Eagle Note, the "Notes") from the Company in the aggregate principal amount of $102,000, such principal and the interest thereon convertible into shares of the Company's common stock at the option of GSC.

The maturity date of the Notes is October 11, 2019 (the "Maturity Date"). The Notes shall bear interest at a rate of eight percent (8%) per annum (the "Interest Rate"), which interest shall be paid by the Company to the Investors in shares of common stock at any time Eagle or GSC sends a notice of conversion to the Company (the "Notice of Conversion"). The Investors are entitled to, at their option, convert all or any amount of the principal face amount and any accrued but unpaid interest of their respective Notes into shares of the Company's common stock, at any time, at a conversion price for each share of common stock equal to 65% multiplied by the lowest closing bid price of the common stock as reported on the marketplace upon which the Company's shares are traded during the fifteen (15) trading day period ending on the day upon which a Notice of Conversion is received by the Company. In connection with this note, the Company recorded a $149,702 and $85,085 debt discounts.

The Notes may be prepaid until 180 days from the issuance date in accordance with its terms.

The Company shall reserve 532,000,000, and 299,000,000, of its authorized and unissued common stock free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of the Eagle Note (the "Eagle Reserved Amount"), and the GSC Note (the "GSC Reserved Amount" and together with the Eagle Reserved Amount, the "Total Reserved Amount"), respectively.

The maturity date of the GSC Note is December 19, 2019 (the "the GSC Maturity Date"). The GSC Note shall bear interest at a rate of eight percent (8%) per annum (the "GSC Interest Rate"), which interest shall be paid by the Company to GSC in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company's common stock, at any time, at the conversion price specified in the for each share of common stock equal to 67% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note, the Company recorded a $76,000 debt discount.

The GSC Note may be prepaid until 180 days from the issuance date in accordance with its terms.

GS Capital Agreement

The maturity date of the GS Capital note is March 7, 2020. The GS Capital Note shall bear interest at a rate of eight percent (8%) per annum which interest shall be paid by the Company to GS Capital in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company's common stock, at any time, at the conversion price specified in the for each share of common stock equal to 65% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note, the Company recorded a $167,296 debt discount.

XML 24 R14.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Stockholders' Deficit

8.	Stockholders’ Deficit

Preferred Stock

Series A Preferred Stock

Series B Preferred Stock

During the year ended December 31, 2018 investors converted 189,700 Series B Preferred stock in to 1,897,000,000 shares of common stock.

Common Stock

On January 15, 2019, the Company issued 165,546,562 shares of common stock for a cashless exercise on warrants.

XML 25 R15.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

9.	Commitments and Contingencies

Distribution and License Agreement and Joint Development Agreements

Litigation

However, there can be no assurance with respect to such result, and monetary liability or financial impact to the Company from these other matters could differ materially from those projected.

XML 26 R16.htm IDEA: XBRL DOCUMENT

Subsequent Events

3 Months Ended

Mar. 31, 2019

Subsequent Events [Abstract]

Subsequent Events

10.

Subsequent Events

LG Note

On May 2, 2019, the Company entered into a securities purchase agreement with LG Capital Funding, LLC ("LG Capital") for the sale of two 8% convertible redeemable notes in the original principal amount of $63,945, or an aggregate principal amount of $127,890 (the "LG Note"), which included an aggregate payment of $126,000 to the Company at an original issue discount of $1,890.

The LG Note bears interest at the rate of 8% per annum. All interest and principal must be repaid on May 2, 2020. The LG Note is convertible into common stock at any time after the six-month anniversary of the LG Note, at LG Capital's option, at a price equal to 65% of the average of the two lowest closing trading prices of the common stock during the fifteen-day period prior to conversion. The LG Note may not be prepaid more than 180 days prior to its maturity date. In the event the Company prepays the LG Note in full during the 180 days prior to its maturity date, the Company must pay off all principal, interest and any other amounts owing multiplied by a premium ranging from 5% to 30%.

The LG Note was offered and sold to LG Capital in a private placement transaction made in reliance upon exemptions from registration pursuant to Section 4(a)(2) under the Securities Act of 1933 (the "Securities Act") and/or Rule 506 promulgated under the Securities Act. LG Capital is an accredited investor as defined in Rule 501 of Regulation D promulgated under the Securities Act.

Odyssey Note

On May 7, 2019, the Company entered into a securities purchase agreement (the "Securities Purchase Agreement") with Odyssey Capital Funding, LLC ("Odyssey") for the sale of an 12% convertible redeemable note in the amount of $100,000 (the "Odyssey Note").

The Odyssey Note bears interest at the rate of 12% per annum. All interest and principal must be repaid on May 7, 2020. The Odyssey Note is convertible into common stock at any time after the six-month anniversary of the Odyssey Note, at Odyssey's option, at a price equal to 60% of the lowest closing trading price of the common stock during the twenty day period prior to conversion. The Odyssey Note may not be prepaid more than 180 days prior to its maturity date. In the event the Company prepays the Note in full during the 180 days prior to its maturity date, the Company must pay off all principal, interest and any other amounts owing multiplied by a premium ranging from 25% to 45%.

The Odyssey Note was offered and sold to Odyssey in a private placement transaction made in reliance upon exemptions from registration pursuant to Section 4(a)(2) under the Securities Act of 1933 (the "Securities Act") and/or Rule 506 promulgated under the Securities Act. Odyssey is an accredited investor as defined in Rule 501 of Regulation D promulgated under the Securities Act.

XML 27 R17.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Basis of Presentation - Unaudited Interim Financial Information

Basis of Presentation - Unaudited Interim Financial Information

The accompanying unaudited interim condensed consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the "SEC") with respect to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company's annual report on Form 10-K for the year ended December 31, 2018.

Use of Estimates

Use of Estimates

Concentration of Risk Related to Third-party Suppliers

Concentration of Risk Related to Third-party Suppliers

Fair Value of Financial Instruments

Fair Value of Financial Instruments

	Level 1	Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurable date.

	Level 2	Inputs, other than quoted prices included in Level 1, that are observable for the asset or liability through corroboration with market data at the measurement date.

	Level 3	Unobservable inputs that reflect management's best estimate of what participants would use in pricing the asset or liability at the measurement date.

Business Segments

Business Segments

ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company's condensed consolidated financial statements as substantially all of the Company's operations are conducted in one industry segment.

Cash

Cash

Accounts Receivable and Allowance for Doubtful Accounts

Accounts Receivable and Allowance for Doubtful Accounts

During the three months ended March 31, 2019 and 2018 the Company recorded a bad debt expense of $0 and $0, respectively.

Inventory

Inventory

Property and Equipment

Property and Equipment

Property and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the useful life as follows:

Internal-use software		3 years
Equipment		3 to 5 years
Computer equipment		3 to 7 years
Furniture and fixtures		5 to 7 years
Leasehold improvements		Shorter of life of asset or lease

Accounting for Website Development Costs

Accounting for Website Development Costs

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

Debt Discount and Debt Issuance Costs

Debt Discount and Debt Issuance Costs

Derivative Liability

Derivative Liability

Revenue Recognition

Revenue Recognition

1)	Identify the contract with a customer

2)	Identify the performance obligations in the contract

3)	Determine the transaction price

The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring services to the customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Company's judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company's contracts as of December 31, 2018 contained a significant financing component. Determining the transaction price requires significant judgment, which is discussed by revenue category in further detail below.

4)	Allocate the transaction price to performance obligations in the contract

5)	Recognize revenue when or as the Company satisfies a performance obligation

	Three Months ended March 31, 2019						Three Months ended March 31, 2018
	United States		International		Total		United States		International		Total
Product Revenue		494		757		1,251		39,666		27,178		66,844
Product Service Revenue		288		-		288		3,468		1,987		5,455
Licensing Revenue		-		-		-		4,130				4,130
		782		757		1,539		47,264		29,165		76,429

Product revenue

Revenue from multiple-element arrangements is allocated among separate elements based on their estimated sales prices, provided the elements have value on a stand-alone basis.

Licensing revenue

Warranty

Warranty

Product Returns

Product Returns

Customer Deposits

Customer Deposits

Research and Development Costs

Research and Development Costs

Advertising Costs

Advertising Costs

Advertising costs are charged to sales and marketing expenses and general and administrative expenses as incurred. Advertising expenses, which are recorded in sales and marketing and general and administrative expenses, totaled $54,290 and $52,253 for the three months ended March 31, 2019 and 2018, respectively.

Stock-Based Compensation

Stock-Based Compensation

Collaborative Arrangements

Collaborative Arrangements

Earnings per Share

Earnings per Share

The following table provides a reconciliation of the numerator and denominator used in computing basic and diluted net income (loss) attributable to common stockholders per common share.

	For the Three Months Ended
	March 31, 2019			March 31, 2018
Numerator:
Net income/(loss) attributable to common stockholders	$	294,370		$	879,905
Effect of dilutive securities:		-			-
Convertible note - Interest Expense		20,241			8,751
Change in Warrant liability		(815,970	)		-
Net Change in derivative liabilities - convertible payables		(135,244	)		(1,365,055	)

Diluted net income (loss)	$	(636,603	)	$	(476,399	)

Denominator:
Weighted average common shares outstanding - basic		4,043,156,414			1,878,730,874
Dilutive securities (a):
Series A Preferred		51			51
Series B Preferred		1,070,000,000			2,967,000,000
Convertible notes payable		738,212,072			128,586,957
Convertible accounts payable		330,000,000			346,554,654
Options		-			-
Warrants		1,615,879,300			-

Weighted average common shares outstanding and assumed conversion - diluted		7,797,250,837			5,320,872,536

Basic net income (loss) per common share	$	0.00		$	0.00

Diluted net loss per common share	$	(0.00	)	$	(0.00	)

(a) - Anti-dilutive securities excluded:		9,067,645			261,835,149

Recent Accounting Guidance Adopted

Recent Accounting Guidance Adopted

As part of the adoption we elected the practical expedients permitted under the transition guidance within the new standard, which among other things, allowed us to:

	1.	Continue applying our current policy for accounting for land easements that existed as of, or expired before, January 1, 2019.

	2.	Not separate non-lease components from lease components and instead to account for each separate lease component and the non-lease components associated with that lease component as a single lease component.

	3.	Not to apply the recognition requirements in ASC 842 to short-term leases.

	4.	Not record a right of use asset or right of use liability for leases with an asset or liability balance that would be considered immaterial.

XML 28 R18.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Schedule of depreciation and amortization are provided using the straight-line method over the useful life

Internal-use software		3 years
Equipment		3 to 5 years
Computer equipment		3 to 7 years
Furniture and fixtures		5 to 7 years
Leasehold improvements		Shorter of life of asset or lease

Schedule of sales by operating segment disaggregated based on type of product and geographic region

	Three Months ended March 31, 2019						Three Months ended March 31, 2018
	United States		International		Total		United States		International		Total
Product Revenue		494		757		1,251		39,666		27,178		66,844
Product Service Revenue		288		-		288		3,468		1,987		5,455
Licensing Revenue		-		-		-		4,130				4,130
		782		757		1,539		47,264		29,165		76,429

Schedule of reconciliation of the numerator and denominator used in computing basic and diluted net income (loss) attributable to common stockholders per common share

	For the Three Months Ended
	March 31, 2019			March 31, 2018
Numerator:
Net income/(loss) attributable to common stockholders	$	294,370		$	879,905
Effect of dilutive securities:		-			-
Convertible note - Interest Expense		146,353			8,751
Net Change in derivative liabilities - convertible payables		(135,244	)		(1,365,055	)

Diluted net income (loss)	$	305,479		$	(476,399	)

Denominator:
Weighted average common shares outstanding - basic		4,043,156,414			1,878,730,874
Dilutive securities (a):
Series A Preferred		51			51
Series B Preferred		1,070,000,000			2,967,000,000
Convertible notes payable		691,424,353			128,586,957
Convertible accounts payable		3,000,000			346,554,654
Options		-			-
Warrants		2,343,120,568			-

Weighted average common shares outstanding and assumed conversion - diluted		8,150,701,386			5,320,872,536

Basic net income (loss) per common share	$	0		$	0

Diluted net loss per common share	$	0		$	(0	)

(a) - Anti-dilutive securities excluded:		2,366,340			261,835,149

XML 29 R19.htm IDEA: XBRL DOCUMENT

Inventory (Tables)

3 Months Ended

Mar. 31, 2019

Inventory Disclosure [Abstract]

Schedule of inventory

	March 31,		December 31,
	2019		2018
Finished goods	$	7,511	$	9,781
Raw materials		150,445		104,250
	$	157,956	$	114,031

XML 30 R20.htm IDEA: XBRL DOCUMENT

Debt (Tables)

3 Months Ended

Mar. 31, 2019

Debt Disclosure [Abstract]

Schedule of convertible notes

	March 31,			December 31,
	2019			2018
Convertible Note - February 6, 2017		265,750			265,750
Convertible Note - July 23, 2018		25,000			25,000
Convertible Note – October 1, 2018		74,800			74,800
Convertible Note – October 4, 2018		73,500			73,500
Convertible Note – October 11, 2018		283,500			283,500
Convertible Note – December 19, 2018		82,000			82,000
Convertible Note – March 7, 2019		210,000			-
		1,014,550			804,550
Less: Debt Discount		(419,051	)		(368,373	)
Total	$	595,499		$	436,177

XML 31 R21.htm IDEA: XBRL DOCUMENT

Derivative Liabilities (Tables)

3 Months Ended

Mar. 31, 2019

Schedule of Binomial-lattice model assumptions used to estimate the fair value of the derivative liability and warrant liability

	Low			High
Annual dividend rate		0	%		0	%
Expected life in years		.32			1.00
Risk-free interest rate		2.40	%		2.44	%
Expected volatility		103	%		114	%

Schedule of changes in the derivative liabilities

Three Months Ended March 31, 2019

Level 1

Level 2

Level 3

Derivative Liability as of January 1, 2019

1,222,186

Initial derivative expense

166,790

Gain on changes in fair value

(135,244

)

Derivative liabilities as of March 31, 2019

1,253,732

Warrant [Member]

Schedule of changes in the derivative liabilities

	Three Months Ended March 31, 2019
	Level 1		Level 2		Level 3
Balance, January 1, 2019	$	-	$	-	$	6,267,426
Change due to exercise of warrants						(845,883	)
Gain on changes in fair value		-		-		(815,970	)
Accretion of warrant expense		-		-		245,775
Warrant liabilities as March 31, 2019	$	-	$	-	$	4,851,348

XML 32 R22.htm IDEA: XBRL DOCUMENT

Going Concern (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018	Dec. 31, 2017
Going Concern (Textual)
Cash	$ 175,504	$ 102,698	$ 37,590	$ 119,028

XML 33 R23.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details)	3 Months Ended
Summary of Significant Accounting Policies (Details)	Mar. 31, 2019
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	3 years
Software Development [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	3 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment useful life method, description	Shorter of life of asset or lease
Minimum [Member] \| Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	3 years
Minimum [Member] \| Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	3 years
Minimum [Member] \| Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	5 years
Maximum [Member] \| Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	7 years
Maximum [Member] \| Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	5 years
Maximum [Member] \| Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	7 years

XML 34 R24.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details 1) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Total	$ 1,539	$ 76,429
Product revenue [Member]
Total	1,251	66,844
Product service revenue [Member]
Total	288	5,455
Licensing revenue [Member]
Total		4,130
United States [Member]
Total	782	47,264
United States [Member] \| Product revenue [Member]
Total	494	39,666
United States [Member] \| Product service revenue [Member]
Total	288	3,468
United States [Member] \| Licensing revenue [Member]
Total		4,130
International [Member]
Total	757	29,165
International [Member] \| Product revenue [Member]
Total	757	27,178
International [Member] \| Product service revenue [Member]
Total		1,987
International [Member] \| Licensing revenue [Member]
Total

XML 35 R25.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details 2) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Numerator:
Net income/(loss) attributable to common stockholders	$ 294,370	$ 879,905
Effect of dilutive securities:
Convertible note - Interest expense	20,241	8,751
Change in Warrant liability	(815,970)
Net change in derivative liabilities - convertible payables	(135,244)	(1,365,055)
Diluted net income (loss)	$ (636,603)	$ (476,399)
Denominator:
Weighted average common shares outstanding - basic	4,043,156,414	1,878,730,874
Weighted average common shares outstanding and assumed conversion - diluted	7,797,250,837	5,320,872,536
Basic net income (loss) per common share	$ (0.00)	$ 0
Diluted net loss per common share	$ (0.00)	$ 0
(a) - Anti-dilutive securities excluded:	9,067,645	261,835,149
Options [Member]
Denominator:
Weighted average common shares outstanding - basic
Warrants [Member]
Denominator:
Weighted average common shares outstanding - basic	1,615,879,300
Series A Preferred [Member]
Denominator:
Weighted average common shares outstanding - basic	51	51
Series B Preferred [Member]
Denominator:
Weighted average common shares outstanding - basic	1,070,000,000	2,967,000,000
Convertible notes payable [Member]
Denominator:
Weighted average common shares outstanding - basic	738,212,072	128,586,957
Convertible accounts payable
Denominator:
Weighted average common shares outstanding - basic	330,000,000	346,554,654

XML 36 R26.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Summary of Significant Accounting Policies (Textual)
Allowance for doubtful accounts	$ 27,851		$ 27,851
Research and development expenses	13,935	$ 233,090
Bad debt expense	0	0
General and Administrative Expenses [Member]
Summary of Significant Accounting Policies (Textual)
Advertising expense	54,290	37,253
Sales and Marketing [Member]
Summary of Significant Accounting Policies (Textual)
Advertising expense	$ 54,290	$ 37,253

XML 37 R27.htm IDEA: XBRL DOCUMENT

Inventory (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Finished goods	$ 7,511	$ 9,781
Raw materials	150,445	104,250
Inventory	$ 157,956	$ 114,031

XML 38 R28.htm IDEA: XBRL DOCUMENT

Debt (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Convertible note	$ 1,014,550	$ 804,550
Less: Debt Discount	(419,051)	(368,373)
Total	595,499	436,177
Convertible Note - February 6, 2017 [Member]
Convertible note	265,750	265,750
Convertible Note - July 23, 2018 [Member]
Convertible note	25,000	25,000
Convertible Note – October 1, 2018 [Member]
Convertible note	74,800	74,800
Convertible Note – October 4, 2018 [Member]
Convertible note	73,500	73,500
Convertible Note – October 11, 2018 [Member]
Convertible note	283,500	283,500
Convertible Note – December 19, 2018 [Member]
Convertible note	82,000	82,000
Convertible Note - March 7, 2019 [Member]
Convertible note	$ 210,000

XML 39 R29.htm IDEA: XBRL DOCUMENT

Debt (Details Textual) - USD ($)					1 Months Ended					3 Months Ended	12 Months Ended
Debt (Details Textual) - USD ($)	Mar. 07, 2019	Oct. 11, 2018	Oct. 05, 2018	Oct. 01, 2018	Dec. 19, 2018	Oct. 11, 2018	Oct. 11, 2018	Jul. 23, 2018	Dec. 27, 2017	Mar. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Oct. 04, 2018	Oct. 02, 2018	Dec. 31, 2016
Geneva Securities Purchase Agreement [Member]
Debt (Textual)
Convertible note principal payment				$ 74,800
Purchase price														$ 74,800
Related party net proceeds				$ 65,000
Convertible shares of common stock				270,905,432
Maturity date term				170 days
Common stock, conversion features, description				The maturity date of the Geneva Note is October 1, 2019 (the "Geneva Maturity Date"). The Geneva Note shall bear interest at a rate of ten percent (10%) per annum (the "Geneva Interest Rate"), which interest shall be paid by the Company to Geneva in shares of common stock at any time Geneva sends a notice of conversion to the Company. Geneva is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the Geneva Note into shares of the Company's common stock, at any time after March 20, 2019, at a conversion price for each share of common stock equal to 71% multiplied by the average of the lowest three (3) trading prices (as defined in the Geneva Purchase Agreement) for the common stock during the fifteen (15) Trading Day period (as defined in the Geneva Purchase Agreement) ending on the latest complete trading day prior to the conversion date.
Interest rate percentage				10.00%
GS Capital Securities Purchase Agreement [Member]
Debt (Textual)
Convertible note principal amount		$ 102,000				$ 102,000	$ 102,000
Convertible note principal payment													$ 75,000
Purchase price													$ 75,000
Related party net proceeds		$ 90,000	$ 68,500
Convertible shares of common stock		299,000,000	211,267,000
Maturity date term			180 days
Common stock, conversion features, description			The maturity date of the GSC Note is October 4, 2019 (the "the GSC Maturity Date"). The GSC Note shall bear interest at a rate of eight percent (8%) per annum (the "GSC Interest Rate"), which interest shall be paid by the Company to GSC in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company's common stock, at any time, at the conversion price specified in the for each share of common stock equal to 71% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note the Company recorded a $58,855 debt discount.
Interest rate percentage		8.00%				8.00%	8.00%						8.00%
Eagle and GSC Securities Purchase Agreements [Member]
Debt (Textual)
Maturity date term							180 days
Common stock, conversion features, description							The purchase price of $181,500, and of $102,000, of the Eagle Note and the GSC Note, respectively, was paid in cash by the Investors on October 11, 2018. After payment of transaction-related expenses, net proceeds to the Company from the Eagle Note and the GSC Note totaled $157,000 and $90,000, respectively. The maturity date of the Notes is October 11, 2019 (the "Maturity Date"). The Notes shall bear interest at a rate of eight percent (8%) per annum (the "Interest Rate"), which interest shall be paid by the Company to the Investors in shares of common stock at any time Eagle or GSC sends a notice of conversion to the Company (the "Notice of Conversion"). The Investors are entitled to, at their option, convert all or any amount of the principal face amount and any accrued but unpaid interest of their respective Notes into shares of the Company's common stock, at any time, at a conversion price for each share of common stock equal to 65% multiplied by the lowest closing bid price of the common stock as reported on the marketplace upon which the Company's shares are traded during the fifteen (15) trading day period ending on the day upon which a Notice of Conversion is received by the Company. In connection with this note, the Company recorded a $149,702 and $85,085 debt discounts.
Eagle Purchase Agreement [Member]
Debt (Textual)
Convertible note principal amount		$ 181,500				$ 181,500	$ 181,500
Related party net proceeds						$ 157,000
Convertible shares of common stock						532,000,000
Interest rate percentage		8.00%				8.00%	8.00%
GS Capital Partners [Member]
Debt (Textual)
Common stock, conversion features, description	Effective March 7, 2019 the Company entered into a securities purchase agreement with GS Capital Partners, pursuant to which GSC purchased a 8% unsecured convertible promissory note from the Company in aggregate principal amount of $210,000, such principal and interest thereon convertible into shares of the Company's common stock at the option of GSC. The purchase price of $210,000 of the GS Capital note was paid in cash by GS Capital on March 11, 2019. After payment of transaction-related expenses, net proceeds to the Company from the note totaled $200,000. The maturity date of the GS Capital note is March 7, 2020. The GS Capital Note shall bear interest at a rate of eight percent (8%) per annum which interest shall be paid by the Company to GS Capital in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company's common stock, at any time, at the conversion price specified in the for each share of common stock equal to 65% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note, the Company recorded a $167,296 debt discount.
GSC Purchase Agreement [Member]
Debt (Textual)
Common stock, conversion features, description					Effective December 19, 2018 the Company entered into a securities purchase agreement (the "GSC Purchase Agreement") with GS Capital Partners LLC, ("GSC", and together with Geneva, the "Investors"), pursuant to which GSC purchased a 8% unsecured convertible promissory note from the Company in the aggregate principal amount of $82,000 (the "GSC Note"), such principal and the interest thereon convertible into shares of the Company's common stock at the option of GSC. The purchase price of $82,000 of the GSC Note was paid in cash by GSC on December 19, 2018. After payment of transaction-related expenses, net proceeds to the Company from the First GSC Note totaled $76,000. The maturity date of the GSC Note is December 19, 2019 (the "the GSC Maturity Date"). The GSC Note shall bear interest at a rate of eight percent (8%) per annum (the "GSC Interest Rate"), which interest shall be paid by the Company to GSC in shares of common stock at any time GSC sends a notice of conversion to the Company. GSC is entitled to, at its option, convert all or any amount of the principal face amount and any accrued but unpaid interest of the GSC Note into shares of the Company's common stock, at any time, at the conversion price specified in the for each share of common stock equal to 67% of the average of the three lowest closing bid prices of the common stock for the fifteen prior trading days including the day upon which a notice of conversion is received by the Company or its transfer agent. In connection with this note, the Company recorded a $76,000 debt discount. The GSC Note may be prepaid until 180 days from the issuance date in accordance with its terms. The Company shall reserve 211,267,000 of its authorized and unissued common stock (the "GSC Reserved Amount"), free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of the GSC Note.
Note purchase agreement [Member]
Debt (Textual)
Received additional proceeds										$ 200,000	$ 30,000
Hasfer assigned amount											60,000
Lenders [Member]
Debt (Textual)
Convertible note principal amount								$ 25,000			$ 60,000
Mature interest and principal due date								Jul. 23, 2019
Convertible conversion price equal discount								30.00%
Derivative liability debt discount								$ 19,070
Interest rate percentage								12.00%
Converted into common stock shares											26,086,956
Hasfer, Inc [Member] \| Amendment [Member]
Debt (Textual)
Convertible note principal amount												$ 236,250
Proceeds from notes payable									$ 48,500
Debt discount and debt issuance costs									1,500
Loss on extinguishment of debt									$ 155,086
Converted into common stock shares												99,891,304
Outstanding balance convertible debt												$ 295,750			$ 0

XML 40 R30.htm IDEA: XBRL DOCUMENT

Derivative Liabilities (Details)	3 Months Ended
Derivative Liabilities (Details)	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Annual dividend rate	0.00%
Low [Member] \| Fair value of derivative liability and warrant liability [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Annual dividend rate	0.00%
Expected life in years	3 months 26 days
Risk-free interest rate	2.40%
Expected volatility	103.00%
High [Member] \| Fair value of derivative liability and warrant liability [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Annual dividend rate	0.00%
Expected life in years	1 year
Risk-free interest rate	2.44%
Expected volatility	114.00%

XML 41 R31.htm IDEA: XBRL DOCUMENT

Derivative Liabilities (Details 1) - Derivative Liabilities [Member]	3 Months Ended
	Mar. 31, 2019 USD ($)
Level 1 [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative Liability as of January 1, 2019
Gain on changes in fair value
Derivative liabilities as of March 31, 2019
Level 2 [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative Liability as of January 1, 2019
Gain on changes in fair value
Derivative liabilities as of March 31, 2019
Level 3 [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative Liability as of January 1, 2019	1,222,186
Initial derivative expense	166,790
Gain on changes in fair value	(135,244)
Derivative liabilities as of March 31, 2019	$ 1,253,732

XML 42 R32.htm IDEA: XBRL DOCUMENT

Derivative Liabilities (Details 2) - Warrant [Member]	3 Months Ended
Derivative Liabilities (Details 2) - Warrant [Member]	Mar. 31, 2019 USD ($)
Level 1 [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Balance, January 1, 2019
Change due to exercise of warrants
Gain on changes in fair value
Warrant liabilities as March 31, 2019
Level 2 [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Balance, January 1, 2019
Change due to exercise of warrants
Gain on changes in fair value
Warrant liabilities as March 31, 2019
Level 3 [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Balance, January 1, 2019	6,267,426
Change due to exercise of warrants	(845,883)
Gain on changes in fair value	(815,970)
Accretion of warrant expense	245,775
Warrant liabilities as March 31, 2019	$ 4,851,348

XML 43 R33.htm IDEA: XBRL DOCUMENT

Derivative Liabilities (Details Textual)	3 Months Ended
Derivative Liabilities (Details Textual)	Mar. 31, 2019
Derivative Liabilities (Textual)
Dividend yield	0.00%

XML 44 R34.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit (Details) - USD ($)	1 Months Ended		3 Months Ended	12 Months Ended
Stockholders' Deficit (Details) - USD ($)	Jul. 31, 2018	Jul. 30, 2018	Mar. 31, 2019	Dec. 31, 2018	Jan. 15, 2019	Mar. 31, 2018	Sep. 30, 2016
Stockholders' Deficit (Textual)
Common stock, par value			$ 0.001	$ 0.001
Common stock, shares authorized			10,000,000,000	10,000,000,000
Common stock issued for cashless exercise on warrants			4,070,747,508	3,905,200,946
Blank Check Preferred Stock [Member]
Stockholders' Deficit (Textual)
Preferred stock, par value							$ 0.001
Authorize for issuance of shares of blank check preferred stock							10,000,000
Common Stock [Member]
Stockholders' Deficit (Textual)
Converted common stock, shares				1,897,000,000
Common stock, shares authorized							10,000,000,000
Common stock issued for cashless exercise on warrants					165,546,562
Series A Preferred Stock [Member]
Stockholders' Deficit (Textual)
Preferred stock, par value			$ 0.001	$ 0.001		$ 0.001
Preferred stock, description			The Series A Preferred Stock can convert into common stock at a 1:1 ratio. Each one (1) share of the Series A Preferred shall have voting rights equal to (x) 0.019607 multiplied by the total issued and outstanding shares of Common Stock eligible to vote at the time of the respective vote (the ?Numerator?), divided by (y) 0.49, minus (z) the Numerator. For purposes of illustration only, if the total issued and outstanding shares of Common Stock eligible to vote at the time of the respective vote is 5,000,000, the voting rights of one share of the Series A Preferred Stock shall be equal to 102,036 (0.019607 x 5,000,000) / 0.49) ? (0.019607 x 5,000,000) = 102,036). On December 23, 2016 the 51 shares were issued to Mr. Yazbeck, the Company?s sole officer and the sole member of the Board. Mr. Yazbeck, via his ownership of the 51 shares of the Series A Preferred, has control of the majority of the Company?s voting stock.
Preferred stock, shares issued			51	51		51
Preferred stock, shares outstanding			51	51		51
Preferred stock designated			51			51
Series B Preferred Stock [Member]
Stockholders' Deficit (Textual)
Converted common stock, shares				189,700
Preferred stock, par value	$ 1.00	$ 1.00
Preferred stock, description			The Series B Preferred is convertible into shares of Common Stock at a conversion price of $0.0001. Holders of the Series B Preferred are entitled to receive dividends annually equal to $0.10 for each share of Series B Preferred held. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series B Preferred then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders, before any payment shall be made to the holders of Common Stock. Until such time as there are fewer than 20,000 shares of Series B Preferred outstanding.
Preferred stock, shares issued	38,272	45,355
Description of issuance warrants	The Company also agreed to the assignment or issuance of three warrants giving the holder the right to purchase seven and one half percent (7.5%) of the Company?s shares of Common Stock issued and outstanding at the time of exercise and having an exercise price of $0.001 per share. This form of warrant is referred to herein as the ?7.5% Warrant.? The Company agreed to the assignment of one previously issued 7.5% Warrant to an entity related to BCI Advisors. This 7.5% Warrant will expire on July 31, 2020. In addition, the Company also agreed to the assignment of another previously issued 7.5% Warrant to an entity related to BCI Advisors and agreed to extend the expiration date from March 1, 2019 to July 31, 2020. Finally, the Company agreed to issue a new 7.5% Warrant which will expire on July 31, 2020. The Company currently does not have enough authorized shares to issue the Series B Preferred shares and therefore, have recorded them as a liability at their fair value of $1,262,976.	The Company also agreed to issue a 7.5% Warrant with an expiration date of July 31, 2020. The Company currently does not have enough authorized shares to issue the Series B shares and therefore, have recorded them as a liability at their fair value of $1,587,425.
Liability, at fair value	$ 1,262,976	$ 1,587,425

XML 45 R35.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details)	3 Months Ended
Commitments and Contingencies (Details)	Mar. 31, 2019
Commitments and Contingencies (Textual)
Royalty, percentage	7.00%

XML 46 R36.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details Textual) - Subsequent Event [Member] - USD ($)	1 Months Ended
	May 07, 2019	May 02, 2019
LG Capital Funding, LLC [Member]
Subsequent Events (Textual)
Percentage of convertible redeemable notes		8.00%
Original principal amount		$ 63,945
Aggregate principal amount		127,890
Aggregate payment of amount		126,000
Original issue discount		$ 1,890
Percentage of conversion or exercise does not exceed		4.99%
Interest rate		8.00%
Repaid terms		May 02, 2020
Convertible note, description		The LG Note is convertible into common stock at any time after the six-month anniversary of the LG Note, at LG Capital’s option, at a price equal to 65% of the average of the two lowest closing trading prices of the common stock during the fifteen-day period prior to conversion. The LG Note may not be prepaid more than 180 days prior to its maturity date. In the event the Company prepays the LG Note in full during the 180 days prior to its maturity date, the Company must pay off all principal, interest and any other amounts owing multiplied by a premium ranging from 5% to 30%.
Default interest rate		24.00%
Odyssey Capital Funding, LLC [Member]
Subsequent Events (Textual)
Percentage of convertible redeemable notes	12.00%
Convertible redeemable note amount	$ 100,000
Percentage of conversion or exercise does not exceed	4.99%
Interest rate	12.00%
Convertible note, description	The Odyssey Note is convertible into common stock at any time after the six-month anniversary of the Odyssey Note, at Odyssey’s option, at a price equal to 60% of the lowest closing trading price of the common stock during the twenty day period prior to conversion. The Odyssey Note may not be prepaid more than 180 days prior to its maturity date. In the event the Company prepays the Note in full during the 180 days prior to its maturity date, the Company must pay off all principal, interest and any other amounts owing multiplied by a premium ranging from 25% to 45%.
Default interest rate	24.00%

EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 48 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 150 198 1 false 50 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://cdxlife.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://cdxlife.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://cdxlife.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://cdxlife.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Stockholders' Deficit (Unaudited) Sheet http://cdxlife.com/role/StatementsOfStockholdersDeficit Statements of Stockholders' Deficit (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://cdxlife.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Organization Sheet http://cdxlife.com/role/Organization Organization Notes 7 false false R8.htm 00000008 - Disclosure - Nature of Business Sheet http://cdxlife.com/role/NatureOfBusiness Nature of Business Notes 8 false false R9.htm 00000009 - Disclosure - Going Concern Sheet http://cdxlife.com/role/GoingConcern Going Concern Notes 9 false false R10.htm 00000010 - Disclosure - Summary of Significant Accounting Policies Sheet http://cdxlife.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 00000011 - Disclosure - Derivative Liabilities Sheet http://cdxlife.com/role/DerivativeLiabilities Derivative Liabilities Notes 11 false false R12.htm 00000012 - Disclosure - Inventory Sheet http://cdxlife.com/role/Inventory Inventory Notes 12 false false R13.htm 00000013 - Disclosure - Debt Sheet http://cdxlife.com/role/Debt Debt Notes 13 false false R14.htm 00000014 - Disclosure - Stockholders' Deficit Sheet http://cdxlife.com/role/StockholdersDeficit Stockholders' Deficit Notes 14 false false R15.htm 00000015 - Disclosure - Commitments and Contingencies Sheet http://cdxlife.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 00000016 - Disclosure - Subsequent Events Sheet http://cdxlife.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 00000017 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://cdxlife.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://cdxlife.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://cdxlife.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://cdxlife.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 00000019 - Disclosure - Inventory (Tables) Sheet http://cdxlife.com/role/InventoryTables Inventory (Tables) Tables http://cdxlife.com/role/Inventory 19 false false R20.htm 00000020 - Disclosure - Debt (Tables) Sheet http://cdxlife.com/role/DebtTables Debt (Tables) Tables http://cdxlife.com/role/Debt 20 false false R21.htm 00000021 - Disclosure - Derivative Liabilities (Tables) Sheet http://cdxlife.com/role/DerivativeLiabilitiesTables Derivative Liabilities (Tables) Tables http://cdxlife.com/role/DerivativeLiabilities 21 false false R22.htm 00000022 - Disclosure - Going Concern (Details) Sheet http://cdxlife.com/role/GoingConcernDetails Going Concern (Details) Details http://cdxlife.com/role/GoingConcern 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://cdxlife.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://cdxlife.com/role/SummaryOfSignificantAccountingPoliciesTables 23 false false R24.htm 00000024 - Disclosure - Summary of Significant Accounting Policies (Details 1) Sheet http://cdxlife.com/role/SummaryOfSignificantAccountingPoliciesDetails1 Summary of Significant Accounting Policies (Details 1) Details http://cdxlife.com/role/SummaryOfSignificantAccountingPoliciesTables 24 false false R25.htm 00000025 - Disclosure - Summary of Significant Accounting Policies (Details 2) Sheet http://cdxlife.com/role/SummaryOfSignificantAccountingPoliciesDetails2 Summary of Significant Accounting Policies (Details 2) Details http://cdxlife.com/role/SummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 00000026 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://cdxlife.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) Details http://cdxlife.com/role/SummaryOfSignificantAccountingPoliciesTables 26 false false R27.htm 00000027 - Disclosure - Inventory (Details) Sheet http://cdxlife.com/role/InventoryDetails Inventory (Details) Details http://cdxlife.com/role/InventoryTables 27 false false R28.htm 00000028 - Disclosure - Debt (Details) Sheet http://cdxlife.com/role/DebtDetails Debt (Details) Details http://cdxlife.com/role/DebtTables 28 false false R29.htm 00000029 - Disclosure - Debt (Details Textual) Sheet http://cdxlife.com/role/DebtDetailsTextual Debt (Details Textual) Details http://cdxlife.com/role/DebtTables 29 false false R30.htm 00000030 - Disclosure - Derivative Liabilities (Details) Sheet http://cdxlife.com/role/DerivativeLiabilitiesDetails Derivative Liabilities (Details) Details http://cdxlife.com/role/DerivativeLiabilitiesTables 30 false false R31.htm 00000031 - Disclosure - Derivative Liabilities (Details 1) Sheet http://cdxlife.com/role/DerivativeLiabilitiesDetails1 Derivative Liabilities (Details 1) Details http://cdxlife.com/role/DerivativeLiabilitiesTables 31 false false R32.htm 00000032 - Disclosure - Derivative Liabilities (Details 2) Sheet http://cdxlife.com/role/DerivativeLiabilitiesDetails2 Derivative Liabilities (Details 2) Details http://cdxlife.com/role/DerivativeLiabilitiesTables 32 false false R33.htm 00000033 - Disclosure - Derivative Liabilities (Details Textual) Sheet http://cdxlife.com/role/DerivativeLiabilitiesDetailsTextual Derivative Liabilities (Details Textual) Details http://cdxlife.com/role/DerivativeLiabilitiesTables 33 false false R34.htm 00000034 - Disclosure - Stockholders' Deficit (Details) Sheet http://cdxlife.com/role/StockholdersDeficitDetails Stockholders' Deficit (Details) Details http://cdxlife.com/role/StockholdersDeficit 34 false false R35.htm 00000035 - Disclosure - Commitments and Contingencies (Details) Sheet http://cdxlife.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://cdxlife.com/role/CommitmentsAndContingencies 35 false false R36.htm 00000036 - Disclosure - Subsequent Events (Details Textual) Sheet http://cdxlife.com/role/SubsequentEventsDetailsTextual Subsequent Events (Details Textual) Details http://cdxlife.com/role/SubsequentEvents 36 false false All Reports Book All Reports mydx-20190331.xml mydx-20190331.xsd mydx-20190331_cal.xml mydx-20190331_def.xml mydx-20190331_lab.xml mydx-20190331_pre.xml http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/srt/2018-01-31 true true ZIP 52 0001213900-19-010344-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-19-010344-xbrl.zip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end